On our 70th Anniversary,
we asked today’s Damon
Runyon scientists how
they think cancer will be
prevented, diagnosed, and
treated dierently in our
lifetimes and our childrens.
Their fascinating responses
give us great optimism.
DAMON RUNYON CANCER RESEARCH FOUNDATION
ANNUAL REPORT 2016
Contents
1615
DAMON RUNYON AWARD
PROGRAMS
REMEMBERING
DALE F. FREY
17
AWARDS AND
COMMITTEES
31
EVENTS
01
PRESIDENT & CEO
03
A LOOK
INTO THE FUTURE
13
BOARD OF
DIRECTORS
32
THANK YOU TO
DONORS
33
SPONSORED
AWARDS
35
CONTRIBUTORS
DAMON RUNYON CANCER RESEARCH FOUNDATION
ANNUAL REPORT 2016
DAMON RUNYON ADVISORS,
BROADWAY
PREMIER CIRCLE
39
40
41
DISCOVERY
SOCIETY
WAYS TO
GIVE
FINANCIALS
42
President & CEO
01
WE ALL DREAM ABOUT THE FUTURE, a time when fewer cancers will
be diagnosed and every cancer patient can be effectively treated. That has
been our goal since our founding 70 years ago. Over that time, our thinking
about cancer has evolved from viewing it as a mysterious killer into a beer
understood disease, driven by genetic mutations that cause cells to multiply
and spread in an uncontrolled manner.
We have more recently witnessed the application of this knowledge
to new ways to prevent, diagnose and cure many forms of cancer. Today,
novel therapies are saving the lives of those who likely would not have even
survived if they were diagnosed in the year 2000. We want this outcome
continued health and survival—to be true for all cancer patients regardless
of cancer type.
This progress would not be possible without brilliant scientists fully
dedicated to this work, which is why the Damon Runyon Cancer Research
Foundation remains so vitally important. Our unique role is to recruit the
best emerging talent to cancer research—young scientists with the creativity,
passion and innovative spirit needed to make the next breakthroughs—and
keep them there.
In the pages that follow, a few of these exceptional Damon Runyon
scientists share their vision for the future. Our goal is to give them the
resources they need to make these predictions a reality.
02
Lorraine W. Egan
President and Chief Executive Officer
Damon Runyon Cancer Research Foundation
SCREENING AT OUR FINGERTIPS
A patient will have the ability to screen for signs of cancer from
their home, providing the opportunity for early diagnosis.
Catching cancer in its earliest stages can
vastly improve outcomes for patients, and
great effort is put toward encouraging
the public to undergo regular screening
tests such as mammograms, prostate
examinations and colonoscopies. If
discovered, benign lumps and polyps can
then be safely removed before they turn
malignant. Ideally, everyone should have
the opportunity to be routinely screened
for signs of cancer, but the financial
burden and available resources make this
a tremendous challenge.
In the future, screening will
be carried out by the patient
with the same device they use
to schedule meetings—the
smartphone.
Revolutionizing
Cancer Screening
Faster processors and increased
functionality from handheld devices will
give individuals the equivalent of a lab
computer in their pockets. Additionally,
nanotechnology and microfluidic
advances have shrunk the equipment
needed to test blood or other bodily
fluids for biomarkers of cancer into
miniature sensors that can be pluged
into phones like a memory card. In a
few years, people will routinely test
themselves at home. Any changes in
cancer biomarkers will be detected early
and the results emailed to oncologists for
a treatment strategy to be organized.
Along with technological advances,
basic biological research to uncover
early-tumor” biomarkers and
enhance the understanding of cancer
progression will be equally critical.
With twin breakthroughs in technology
and biology, ubiquitous smartphone
screening can be at the forefront of
fighting this disease.
WILLIAM RAZZELL, PhD
Damon Runyon Fellow,
Memorial Sloan Keering Cancer
Center, New York
Wrien by
A look into the future
04
“Illness is the night-side of life, a more
onerous citizenship,” wrote Susan Sontag
in 1977. Twenty-seven years later, Sontag
died of myelodysplastic syndrome (MDS),
a subtype of myeloid blood cancers,
which are the focus of the research in my
laboratory at Harvard. Sontag’s words
remind us that we as physician-scientists
have a solemn responsibility to never
give up in our efforts to develop beer
treatments for our patients and to lessen
the burden their illness imposes on them
and on their families.
In the twelve years since Sontag’s
death, we’ve made enormous advances
in understanding how myeloid blood
cancers develop. We’ve defined the
causative mutations and have developed
the ability to sequentially track the
genetic evolution of leukemia in real time
in patients. We can even detect leukemia-
initiating mutations in the blood of
normal individuals before they are aware
of any symptoms or signs of disease.
Armed with this knowledge, we are
poised to prevent myeloid blood cancers,
to diagnose them earlier and to treat
them more selectively and effectively.
In the next 10
20 years, we will
screen for these cancers using blood
testing, much as we currently screen
for diabetes. We will intervene before
full-blown cancer develops using either
targeted drug therapies or gene editing
technology to correct specific cancer-
causing mutations.
In patients who present
with cancer, we will
exploit precision medicine
to tailor our treatment to
the mutational spectrum of
their individual cancer, and
we will target their own
immune system against
specific mutant proteins
in their cancer.
A look into the future
Cancer Treatment As
Unique As Each Patient
ANN MULLALLY, MD
Damon Runyon
Clinical Investigator
Brigham and Women's Hospital,
Boston
Wrien by
05
Luckily for the cancer research community,
science has arrived in the era of genomics.
This is what we’ve been waiting for, and it
is the key to the future of cancer diagnosis
and treatment.
Through deep sequencing of cancer
genomes we can now appreciate the
tremendous diversity of cancers and
the combinations of mutations that
drive them. It will take a village of cancer
researchers (and computers—lots of
computers) to tenaciously hash out the
functions of cancer-associated genes,
and the consequences of mutations
within them, to precisely pinpoint a
cancer’s weaknesses.
Ten to fieen years from now, cancer
patients should expect to have their tumors
fully sequenced aer biopsy. A unique
disease deserves a unique treatment—
sequencing a patients tumor genome will
reveal the specific mutations that are driving
his or her cancer. Pluging these mutations
into computational models will enable
doctors to prescribe treatment combinations
that are as unique as the patient. Perhaps
that will include a vaccine developed from
the tumor’s own mutated proteins to train
the patient’s immune system to recognize
and destroy it. Or perhaps a drug schedule
targeting molecules upon which the cancer
uniquely relies, but not normal cells.
We’ll gradually transition away
from the “one-size-fits-all,
blunt instrument chemothera-
peutics of the past toward the
sophisticated custom-tailored
therapies of the future.
PRECISION & TARGETED TREATMENTS
Cancer treatments will be tailored to the individual, providing
treatment options that are less toxic and more effective.
EMMA WATSON, PhD
Damon Runyon Fellow,
Brigham and Womens Hospital,
Boston
Wrien by
06
ANALYZING THE EARLY STAGES
Understanding how a cell transforms into a cancer cell will
help scientists create therapies for disease prevention.
Biomedical scientists and physicians
are extremely adept at curing cancers
through chemical, surgical, or
immunological interventions. While this
broad and desirable statement applies to
certain patients with treatable cancers, it
does not apply to enough. Furthermore,
rates of cancer incidence and prevalence
continue to increase. What is the cause
of the disparity between failure in
prevention and success at treatment, and
how can we address this challenge?
While cancer immunotherapy has
already heralded the era of treatment-
based precision medicine that will
dominate the next decade, I predict that
the most significant impact of patient-
specific medicine will come from a
Prevention through
Greater Knowledge
greater understanding of the unique path
that each patient’s cells take to transform
a healthy tissue into a malignant tumor.
By systematically character-
izing, defining, and testing cell
networks within individuals,
we will not only understand
what precipitates cancer but
also identify how we can reset
the balance of these cellular
ecosystems to inhibit the
initiation of cancer.
It is with great hope that I consider the
possibility that the next decade of precision
therapies will not be targeted at cancer
treatment, but rather at prevention.
JOSE M. ORDOVAS-
MONTANES, PhD
Damon Runyon Fellow,
Massachuses Institute of
Technology
Wrien by
A look into the future
08
I treat children with brain tumors, a
resilient patient population that suffers
not only from the direct effects of cancer
but also the deleterious effects of the
toxic treatments we must give them to try
to achieve cures. More children die from
brain tumors than from any other type of
cancer. This must and will change.
We are on the cusp of a
scientific revolution. As we
begin to unravel the genome,
epigenome, and transcriptome
of these devastating tumors,
we are also removing the
academic roadblocks that have
stymied research for so long.
I am collaborating with a scientific
community that understands we must
not just stand on our academic laurels
but that we must make “significant” and
“meaningful” discoveries. In the past,
there have been many smart, well-meaning
scientists devoted to pediatric neuro-
oncology research; however, they were
missing a research infrastructure that
brought scientists and patients together.
They were missing a research platform in
which the massive amounts of biological
data (petabytes) could be openly shared in
real-time.
As a scientific community we now have
the technology, the perseverance, and
the cultural academic shi to find cures.
We are no longer conducting research in
scientific silos.
In the future, children with a devastating
brain tumor, no maer where they live,
will be able to have their tumor molecularly
analyzed, and a treatment tailored to
provide them with the best chance possible
for a long, healthy, productive life.
A look into the future
Changing the Way
Science is Done
ANGELA J. WAANDERS,
MD, MPH Damon Runyon-
Dale F. Frey Breakthrough
Scientist, Childrens Hospital
of Philadelphia
Wrien by
CREATING A DATABASE OF KNOWLEDGE
With scientists working together across multiple disciplines and sharing research data,
patients will see more effective and creative treatments developed at a rate never before seen.
09
With brilliant scientists working
in collaboration, developing
new technologies, and seeking
even greater understanding of
cancer, these visions of the future
will become a reality—for us, and
certainly for our children.
12
Damon Runyon Cancer
Research Foundation
Board of Directors
CHAIR
MR. ALAN M. LEVENTHAL
Chairman and Chief
Executive Officer
Beacon Capital Partners, LLC
Boston, Massachusetts
VICE CHAIR
Scientific Programs
WILLIAM G. KAELIN, JR., MD
Howard Hughes Medical Institute
Investigator
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
VICE CHAIR
Investments and Treasurer
MR. LEON G. COOPERMAN
Chairman and Chief
Executive Officer
Omega Advisors, Inc.
New York, New York
VICE CHAIR
Audit and Secretary
SANFORD W. MORHOUSE, ESQ.
Of Counsel
Schulte Roth & Zabel LLP
New York, New York
VICE CHAIR
Board Development
MR. MICHAEL L. GORDON
Chief Executive Officer
Angelo, Gordon & Co.
New York, New York
VICE CHAIR
Development and Marketing
MR. DAVID M. BEIRNE
Chairman
Fantex Holdings, Inc.
Coral Gables, Florida
STEVEN J. BURAKOFF, MD
Director, The Tisch
Cancer Institute
Icahn School of Medicine
at Mount Sinai
Mount Sinai Health System
New York, New York
MS. DEBORAH J. COLEMAN
Legal Counsel
Convexity Capital
Management LP
Boston, Massachusetts
MS. ROBYN COLES
President
TRATE Properties
Boston, Massachusetts
MR. GARY E. ERLBAUM
President
Greentree Properties
Ardmore, Pennsylvania
THOMAS J. FAHEY, JR., MD
Senior Vice President Emeritus
Memorial Sloan Kettering
Cancer Center
New York, New York
MR. BUCK FRENCH
Co-Founder and Chief
Executive Officer
Fantex Holdings, Inc.
San Francisco, California
ELAINE V. FUCHS, PhD
Rebecca C. Lancefield Professor
Howard Hughes Medical Institute
Investigator
Head, Laboratory of Mammalian
Cell Biology and Development
The Rockefeller University
New York, New York
RICHARD B. GAYNOR, MD
Senior Vice President
Global Product Development/
Medical Affairs
Oncology Business Unit
Eli Lilly and Company
Indianapolis, Indiana
TODD R. GOLUB, MD
Chief Scientific Officer
Director, Cancer Program
The Broad Institute of MIT
and Harvard
Charles A. Dana Investigator in
Human Cancer Genetics at the
Dana-Farber Cancer Institute
Professor of Pediatrics at
Harvard Medical School
Howard Hughes Medical Institute
Investigator
Cambridge, Massachusetts
MR. SCOTT GREENSTEIN
President and Chief
Content Officer
SiriusXM
New York, New York
MR. STEVE HAYDEN
Vice Chairman and Chief
Creative Officer (Retired)
Ogilvy & Mather Worldwide
New York, New York
MR. JAY W. IRELAND
President and Chief
Executive Officer
GE Africa
General Electric
Nairobi, Kenya
13
MORANA JOVAN-EMBIRICOS,
PhD
Managing Partner
F2 Capital Ventures, LLP
London, United Kingdom
MR. STEVEN A. KANDARIAN
Chairman, President and
Chief Executive Officer
MetLife, Inc.
New York, New York
MR. NOAH KNAUF
General Partner
Kleiner Perkins Caufield & Byers
San Francisco, California
GABRIELLE LAYTON, PhD
Palo Alto, California
DAVID M. LIVINGSTON, MD
Deputy Director
Dana-Farber/Harvard
Cancer Center
Emil Frei Professor of
Genetics and Medicine
Harvard Medical School
Boston, Massachusetts
MR. DAVID G. MARSHALL
Chairman and Chief
Executive Officer
Amerimar Realty Company
Philadelphia, Pennsylvania
MR. JOHN H. MYERS
Senior Advisor
Angelo, Gordon & Co.
New York, New York
RICHARD J. O’REILLY, MD
Chief, Pediatric Bone Marrow
Transplant Service
Claire L. Tow Chair in Pediatric
Oncology Research
Memorial Sloan Kettering
Cancer Center
New York, New York
MR. ANDREW S. RACHLEFF
Executive Chairman
Wealthfront
Faculty, Stanford Graduate
School of Business
Palo Alto, California
MR. WILLIAM RAVEIS, JR.
Founder, Chairman and CEO
William Raveis Real Estate,
Mortgage & Insurance
Southport, Connecticut
MICHAEL V. SEIDEN, MD, PhD
Senior Vice President and
Chief Medical Officer
McKesson Specialty Health
US Oncology Network
The Woodlands, Texas
MS. KAREN D. SEITZ
Founder and Managing Director
Fusion Partners
New York, New York
NANCY SIMONIAN, MD
Chief Executive Officer
Syros Pharmaceuticals
Cambridge, Massachusetts
MS. CYNTHIA F. SULZBERGER
Palm Beach, Florida
MR. PETER VAN CAMP
Executive Chairman
Equinix, Inc.
Redwood City, California
JAMES A. WELLS, PhD
Chair, Department of
Pharmaceutical Chemistry
Professor, Cellular and
Molecular Pharmacology
University of California,
San Francisco
San Francisco, California
MS. LORRAINE W. EGAN
President and Chief
Executive Officer
Damon Runyon Cancer
Research Foundation
SIDNEY ALTMAN, PhD
Sterling Professor of Molecular,
Cellular and Developmental
Biology
Professor of Chemistry
Yale University, Department
of Chemistry
New Haven, Connecticut
DAVID BALTIMORE, PhD
P r e s i d e n t E m e r i t u s
Robert Andrews Millikan
P r o f e s s o r o f B i o l o g y
C a l i f o r n i a I n s t i t u t e o f T e c h n o l o g y
Pasadena, California
RONALD LEVY, MD
Professor of Medicine
Division of Oncology
Stanford University School
of Medicine
Stanford, California
MRS. CONNIE LURIE
Atherton, California
I. GEORGE MILLER, MD
John F. Enders Professor
of Pediatrics
P r o f e s s o r o f E p i d e m i o l o g y
Molecular Biophysics
and Biochemistry
Yale University School of Medicine
New Haven, Connecticut
HENRY C. PITOT, MD, PhD
Professor Emeritus of Oncology,
Pathology and Laboratory
M e d i c i n e
McArdle Laboratory for
Cancer Research
University of Wisconsin-
Madison School of Medicine
and Public Health
Madison, Wisconsin
MRS. KATHARINE F. PLUM
Hobe Sound, Florida
SAMUEL C. SILVERSTEIN, MD
John C. Dalton Professor
a n d C h a i r m a n , D e p a r t m e n t o f
Physiology and Cellular
B i o p h y s i c s
P r o f e s s o r o f M e d i c i n e
College of Physicians
and Surgeons of
Columbia University
New York, New York
CRAIG B. THOMPSON, MD
President and Chief
Executive Officer
Memorial Sloan Kettering
Cancer Center
New York, New York
MS. VIRGINIA UEBERROTH
Chairman, The Ueberroth
Family Foundation
Corona del Mar, California
MR. ROBERT C. WRIGHT
Senior Advisor
Lee Equity Partners, LLC
New York, New York
ROBERT C. YOUNG, MD
Former Chancellor
Fox Chase Cancer Center
President
RCY Medicine
Philadelphia, Pennsylvania
EMERITUS BOARD MEMBERS
14
The Damon Runyon Cancer Research Foundation was deeply
saddened by the passing of Dale F. Frey, past Chairman of its Board of
Directors, one of its greatest champions and a dear friend. Through
his vision, passion and relentless dedication to cancer research, Dale
had a lasting impact on human life. Under his leadership for over
16 years, the Foundation grew exponentially and funded top young
scientists in cancer research whose discoveries have dramatically
advanced progress against cancer. In 2010, the Dale F. Frey Award for
Breakthrough Scientists was established in his honor to support the
most outstanding young cancer researchers in the nation.
Remembering
Dale F. Frey, 1932-2016
ANGELA N. BROOKS, PhD ROBERT K. MCGINTY, MD, PhD MICHAEL J. SMANSKI, PhD
ANGELA J. WAANDERS, MD, MPH ARUN P. WIITA, MD, PhD
Select Damon Runyon-Dale F. Frey
Breakthrough Scientists
15
Damon Runyon-
Rachle Innovation
Award
Supports the next generation
of exceptionally creative
thinkers with high-risk, high-
reward ideas that have the
potential to significantly impact
our understanding of and
approaches to the prevention,
diagnosis or treatment of cancer.
TWO-YEAR AWARD:
$300,000, with possibility
of extension up to an
additional $300,000
Damon Runyon
Clinical Investigator
Award
Supports early career physician-
scientists conducting patient-
oriented research. The goal
of this innovative program
is to increase the number
of physicians capable of
moving seamlessly between
the laboratory and the
patient’s bedside in search
of breakthrough treatments.
THREE-YEAR AWARD:
$450,000 plus up to
$100,000 for medical
school loan repayment
Damon Runyon
Clinical Investigator
Continuation Grant
Supports Damon Runyon
Clinical Investigators who are
approaching the end of their
original three-year awards and
need extra time and funding to
complete a promising avenue of
research or initiate/continue a
clinical trial.
TWO-YEAR AWARD:
$300,000
Damon Runyon
Fellowship Award
Supports the training of the
brightest postdoctoral scientists
as they embark upon their
research careers. This funding
enables them to be mentored
by established investigators in
leading research laboratories
across the country.
FOUR-YEAR AWARD:
$231,000
Damon Runyon-Sohn
Pediatric Cancer
Fellowship Award
Supports dedicated basic
scientists and clinicians who
conduct research with the
potential to significantly impact
the prevention, diagnosis or
treatment of one or more
pediatric cancers.
FOUR-YEAR AWARD:
$231,000
Damon Runyon-
Dale F. Frey Award
for Breakthrough
Scientists
Supports a select few
Damon Runyon Fellows
who have greatly exceeded
the Foundation’s highest
expectations. This additional
investment in these exceptional
individuals will help catapult
their research careers and
their impact on cancer.
TWO-YEAR AWARD:
$100,000
Damon Runyon
Physician-Scientist
Training Award
Supports and encourages
outstanding recent medical
school graduates to pursue
cancer research careers by
providing them with the
opportunity for a protected
research training experience
under the mentorship of a highly
qualified and gifted mentor.
FOUR-YEAR AWARD:
$460,000 plus up to
$100,000 for medical
school loan repayment
Damon Runyon
Award Programs
*Increased award amount effective July 1, 2016
Damon Runyon Physician-Scientist
MICHAEL DRAZER, MD
Damon Runyon Fellow
KYLE G. DANIELS, PhD
16
CHAIR
KENNETH W. KINZLER, PhD
Professor of Oncology
Director, Ludwig Center
for Cancer Genetics
and Therapeutics
Johns Hopkins University
Kimmel Cancer Center
Baltimore, Maryland
DAFNA BAR-SAGI, PhD
Senior Vice President
Vice Dean for Science
Chief Scientific Officer
NYU Langone Medical Center
New York, New York
MICHAEL A. CALIGIURI, MD
Director, Comprehensive Cancer
Center
CEO, James Cancer Hospital and
Solove Research Institute
JL Marakas Nationwide Insurance
Enterprise Foundation
Professor of Cancer Research
Professor, Departments of
Internal Medicine and
Molecular Virology,
Immunology, and Medical
Genetics
Columbus, Ohio
ABBY F. DERNBURG, PhD
Howard Hughes Medical Institute
Investigator
Professor of Cell and
Developmental Biology
University of California, Berkeley
Lawrence Berkeley National Lab
Berkeley, California
SANJIV SAM GAMBHIR, MD, PhD
Director, Molecular Imaging
Program
Head, Nuclear Medicine Division
Professor of Radiology,
Bioengineering and
Engineering Materials Science
Stanford University School
of Medicine
Stanford, California
TODD R. GOLUB, MD
Chief Scientific Officer
Director, Cancer Program
The Broad Institute of
Harvard and MIT
Charles A. Dana Investigator in
Human Cancer Genetics at the
Dana-Farber Cancer Institute
Professor of Pediatrics at
Harvard Medical School
Howard Hughes Medical
Institute Investigator
Cambridge, Massachusetts
TARUN M. KAPOOR, PhD
Pels Family Professor
Head, Laboratory of
Chemistry and Cell Biology
The Rockefeller University
New York, New York
DAVID G. KIRSCH, MD, PhD
Professor of Radiation Oncology
Professor of Pharmacology
and Cancer Biology
Duke University Medical Center
Durham, North Carolina
RICHARD L. KLEMKE, PhD
Professor, Department of
Pathology
University of California, San Diego
Moores Cancer Center
La Jolla, California
LEWIS L. LANIER, PhD
American Cancer Society
Research Professor
Chair, Department of
Microbiology and Immunology
J. Michael Bishop, MD,
Distinguished Professor
University of California,
San Francisco
Leader, Cancer, Immunity and
Microenvironment Program
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California
STEVEN M. LARSON, MD
Member and Lab Head
Molecular Pharmacology and
Chemistry Program
Sloan Kettering Cancer Center
Donna and Benjamin M. Rosen
Chair in Radiology
Memorial Sloan Kettering
Cancer Center
New York, New York
RONALD LEVY, MD
Professor of Medicine
Division of Oncology
Stanford University School
of Medicine
Stanford, California
JOSHUA T. MENDELL, MD, PhD
Howard Hughes Medical Institute
Investigator
Professor, Department of
Molecular Biology
University of Texas Southwestern
Medical Center
Dallas, Texas
STEPHEN R. QUAKE, DPhil
Howard Hughes Medical
Institute Investigator
Lee Otterson Professor of
Bioengineering and Applied
Physics
Department of Bioengineering
Stanford University
Stanford, California
Damon Runyon-Rachle
Innovation Award Committee
Damon Runyon-Rachleff Innovator
ROBERTO ZONCU, PhD
Damon Runyon-Rachleff Innovator
CHRISTIN E. BURD, PhD
17
CALIFORNIA
SCOTT J. DIXON, PhD*
“Exploring the role of a toxic
endogenous glycolytic
metabolite in tumor suppression
and chemotherapy action” at
Stanford University, Stanford
NICHOLAS T. INGOLIA, PhD
“Cis-regulatory code for the
translational control of gene
expression” at the University
of California, Berkeley
GUILLEM PRATX, PhD
Adding a new dimension to
flow cytometry: radionuclide-
activated cell sorting” at
Stanford University School
of Medicine, Stanford
PETER J. TURNBAUGH, PhD*,
Nadia’s Gift Foundation Innovator
“The gut microbiome: an
unexpected contributor to cancer
drug resistance” at the University
of California, San Francisco
ELÇIN ÜNAL, PhD
“Reducing cancer susceptibility
by attenuating cellular
aging” at the University
of California, Berkeley
ROBERTO ZONCU, PhD*
“Dissecting and disabling the
glucose-mTORC1 signaling
axis in cancer growth” at the
University of California, Berkeley
CONNECTICUT
JASON M. CRAWFORD, PhD*
“Elucidating the bacterial
determinants of
colorectal cancer” at Yale
University, New Haven
MARYLAND
CHRISTOPHER M. JEWELL, PhD
“Harnessing intra-lymph
node controlled release to
study and enhance tumor
immunity” at the University
of Maryland, College Park
MASSACHUSETTS
EMILY P. BALSKUS, PhD
“Understanding and preventing
carcinogenesis caused by the
human microbiota” at Harvard
University, Cambridge
NEW YORK
PIERO D. DALERBA, MD*
Island Outreach
Foundation Innovator
“Using single-cell genomics to
resolve the molecular identity of
cancer stem cells and guide their
pharmacological eradication” at
Columbia University, New York
ARVIN C. DAR, PhD
“Targeting allosteric control
in the Ras-MAPK pathway
for cancer therapy” at the
Icahn School of Medicine at
Mount Sinai, New York
MORITZ F. KIRCHER, MD, PhD
“Raman-MRI nanobeacons:
towards a universal cancer
theranostic agent” at
Memorial Sloan Kettering
Cancer Center, New York
EIRINI P. PAPAPETROU, MD,
PhD
Edward P. Evans
Foundation Innovator
“Dissecting chromosome
hemizygosity with human
pluripotent stem cells” at the
Icahn School of Medicine at
Mount Sinai, New York
OHIO
CHRISTIN E. BURD, PhD*
“Exploiting mutational
specificity to target RAS-driven
melanoma” at The Ohio State
University, Columbus
OREGON
SUMMER L. GIBBS, PhD
and XIAOLIN NAN, PhD
“Studying spatial regulation
of HER2 tumorigenesis with
multispectral super resolution
microscopy (MSSRM)” at
Oregon Health and Science
University, Portland
TEXAS
NING JENNY JIANG, PhD
A single cell integrated
system to dissecting cancer
immunoediting in humans” at
The University of Texas, Austin
WASHINGTON
BRIAN H. SHIRTS, MD, PhD
“Participatory genetics for
defining genotype-phenotype
associations of rare cancer
variants” at the University
of Washington, Seattle
WISCONSIN
PHILIP A. ROMERO, PhD*
“Digital circulating tumor cell
detection using scalable
molecular logic” at the University
of Wisconsin, Madison
*Initial Year
Damon Runyon-Rachle
Innovation Awards
Damon Runyon-Rachleff Innovator
NING JENNY JIANG, PhD
Damon Runyon-Rachleff Innovator
PHILIP A. ROMERO, PhD
18
CHAIR
WILLIAM G. KAELIN, JR., MD
Howard Hughes Medical
Institute Investigator
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
CHAIR ELECT
CHARLES L. SAWYERS, MD
Chair, Human Oncology and
Pathogenesis Program
The Marie-Josée and Henry R.
Kravis Chair
Howard Hughes Medical Institute
Investigator
Memorial Sloan Kettering Cancer
Center
New York, New York
KARLA V. BALLMAN, PhD
Chief of the Division of
Biostatistics and Epidemiology
Department of Healthcare
Policy and Research
Weill Cornell Medicine
New York, New York
DAVID P. CARBONE, MD, PhD
Professor, Division of
Medical Oncology
Director, Thoracic Oncology
Center
Comprehensive Cancer Center
The Ohio State University
Columbus, Ohio
DENNIS A. CARSON, MD
Professor Emeritus
Department of Medicine
Moores Cancer Center
University of California, San Diego
La Jolla, California
BRUCE A. CHABNER, MD
Professor of Medicine
Harvard Medical School
Director of Clinical Research
Massachusetts General
Hospital Cancer Center
Boston, Massachusetts
NANCY E. DAVIDSON, MD
Director, University of
Pittsburgh Cancer Institute
UPMC Cancer Centers
Associate Vice Chancellor
for Cancer Research
Professor of Medicine
Division of Hematology/
Oncology
University of Pittsburgh
School of Medicine
Pittsburgh, Pennsylvania
S. GAIL ECKHARDT, MD
Professor and Head of the
Division of Medicine Oncology
Stapp/Harlow Endowed Chair in
Cancer Research
University of Colorado Denver
and Health Sciences Center
Senior Associate Director of
Translational and Collaborative
Research
University of Colorado Cancer
Center
Aurora, Colorado
HOWARD A. FINE, MD
Director, Weill Cornell Brain
Tumor Center
Associate Director of
Translational Research
Meyer Cancer Center
Weill Cornell Medicine
New York, New York
PATRICIA A. GANZ, MD
Professor, Schools of Medicine
and Public Health
Director, Division of Cancer
Prevention and Control
Research
Jonsson Comprehensive
Cancer Center
University of California,
Los Angeles
Los Angeles, California
AMATO J. GIACCIA, PhD
Jack, Lulu and Sam Willson
Professor in Cancer Biology
Director, Division of Radiation
and Cancer Biology
Department of Radiation
Oncology
Stanford University School
of Medicine
Stanford, California
CARL H. JUNE, MD
Richard W. Vague Professor in
Immunotherapy
Department of Pathology and
Laboratory Medicine
Director Center for Cellular
Immunotherapies
Director Translational Research
Program
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
ANDREW L. KUNG, MD, PhD
Chair and Professor
Department of Pediatrics
Memorial Sloan Kettering
Cancer Center
New York, New York
DREW M. PARDOLL, MD, PhD
Director, Cancer Immunology
Program
Sidney Kimmel Comprehensive
Cancer Center
Abeloff Professorship in
Oncology
Johns Hopkins University
School of Medicine
Baltimore, Maryland
DAVID R. PIWNICA-WORMS,
MD, PhD
Professor and Chair, Department
of Cancer Systems Imaging
Deputy Division Head,
Research Affairs,
Division of Diagnostic Imaging
The University of Texas M.D.
Anderson Cancer Center
Houston, Texas
KORNELIA POLYAK, MD, PhD
Professor of Medicine
Department of Medical Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts
NORMAN E. SHARPLESS, MD
Director, Lineberger
Comprehensive Cancer Center
Wellcome Distinguished
Professor of Cancer Research
Departments of Medicine and
Genetics
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
Damon Runyon Clinical Investigator
Award Committee
19
CALIFORNIA
ARASH ASH ALIZADEH, MD, PhD
“Targeting the malignant
reprogramming of early
hematopoietic progenitors to
mature aggressive human B-cell
lymphomas” with Ronald Levy,
MD, Stanford University School
of Medicine, Stanford
AMI S. BHATT, MD, PhD*
Applying microbiome-based
therapeutics in cancer patients”
with Linda Boxer, MD, PhD, and
Michael Snyder, PhD, Stanford
University School of Medicine,
Stanford
L. ELIZABETH BUDDE, MD, PhD
Damon Runyon-Jake Wetchler
Foundation for Innovative
Pediatric Cancer Research
Clinical Investigator
“Targeting CD123 using chimeric
antigen receptor T cells for
treatment of acute myeloid
leukemia” with Stephen J. Forman,
MD, FACP, City of Hope, Duarte
FLORIDA
MARCO L. DAVILA, MD, PhD
“The development and clinical
translation of an armored CAR T
cell therapy for immune-resistant
B cell malignancies" with Michel
Sadelain, MD, PhD, Memorial
Sloan Kettering Cancer Center,
New York, and Claudio Anasetti,
MD, Moffitt Cancer Center, Tampa
ILLINOIS
JAEHYUK CHOI, MD, PhD*
Doris Duke-Damon Runyon
Clinical Investigator
“Identification of genetic basis of
altered T cell receptor signaling in
cutaneous T cell lymphoma” with
Stephen D. Miller, PhD, and John
D. Crispino, PhD, Northwestern
University, Chicago
MASSACHUSETTS
PRISCILLA K. BRASTIANOS, MD
“Investigation of novel targeted
therapeutic approaches for
brain metastases” with Keith
T. Flaherty, MD, and Tracy T.
Batchelor, MD, Massachusetts
General Hospital, Boston
ALEJANDRO GUTIERREZ, MD
“Mechanisms and therapeutic
targeting of EZH2-dependent
chemoresistance in T-ALL” with
Stuart H. Orkin, MD, and Anthony
G. Letai, MD, PhD, Boston
Children’s Hospital, Boston
PETER S. HAMMERMAN, MD, PhD
“Development of personalized
cancer immunotherapy” with
Kwok-Kin Wong, MD, PhD, F.
Stephen Hodi, Jr., MD, and
Glenn Dranoff, MD, Dana-Farber
Cancer Institute, Boston
GEOFFREY R. OXNARD, MD*
Gordon Family
Clinical Investigator
“Noninvasive genotyping of cell
free plasma DNA (cfDNA) as
a tool for guiding personalized
lung cancer care” with Pasi A.
Janne, MD, PhD, Dana-Farber
Cancer Institute, Boston
ELIEZER M. VAN ALLEN, MD*
“Dissecting response to
conventional and emerging DNA
damage and repair therapies”
with Levi A. Garraway, MD, PhD,
and Philip Kantoff, MD, Dana-
Farber Cancer Institute, Boston
MISSOURI
VIVEK K. ARORA, MD, PhD*
“Defining a targetable oncogenic
dyad in bladder cancer” with Lee
Ratner, MD, PhD, Washington
University, St. Louis
STEPHEN T. OH, MD, PhD
Doris Duke-Damon Runyon
Clinical Investigator
“Targeting aberrant signaling
pathways in myeloproliferative
neoplasms” with Daniel C. Link,
MD, Washington University,
St. Louis
NEW YORK
CHRISTOPHER E. BARBIERI, MD,
PhD*
MetLife Foundation
Clinical Investigator
“Presurgical trials to target
distinct subclasses of localized
prostate cancer” with Mark
A. Rubin, MD, Weill Cornell
Medicine, New York
JOSHUA BRODY, MD
“Flt3L-primed ‘in situ’ vaccination
for low-grade lymphoma-
Phase I/II study of intratumoral
injection of rhuFlt3L and poly-
ICLC with low-dose radiotherapy
[NCT01976585]” with Nina
Bhardwaj, MD, PhD, and Miriam
Merad, MD, PhD, Mount Sinai
Hospital, New York
Damon Runyon Clinical
Investigator Awards
SANDRA L. WONG, MD, MS
Chair, Department of Surgery
Senior Vice President of the
Surgical Services Line
Dartmouth-Hitchcock Medical
Center
The Greisel School of Medicine at
Dartmouth
Lebanon, New Hampshire
Founding Member
RICHARD J. O’REILLY, MD
Chief, Pediatric Bone Marrow
Transplant Service;
Claire L. Tow Chair in Pediatric
Oncology Research
Memorial Sloan Kettering
Cancer Center
New York, New York
Damon Runyon Clinical Investigator
Award Committee
(Continued)
20
Damon Runyon Clinical Investigator Awards (Continued)
Damon Runyon Clinical Investigator Award
Continuation Grants
ALEX KENTSIS, MD, PhD*
Richard Lumsden Foundation
Clinical Investigator
“Mechanism and function of
regulatory signaling in acute
myeloid leukemia” with Scott
A. Armstrong, MD, PhD, Dana-
Farber Cancer Institute, Boston,
and Ross Levine, MD, Memorial
Sloan Kettering Cancer Center,
New York
LUC G. MORRIS, MD
“Functionalizing tumor
suppressor gene mutations
and deletions in head and neck
cancer” with Timothy A. Chan,
MD, PhD, and James A. Fagin,
MD, Memorial Sloan Kettering
Cancer Center, New York
HEATHER L. YEO, MD*
“Use of mobile applications to
evaluate post surgical recovery
in aging patients with GI cancer
Manish A. Shah, MD, and
Deborah Estrin, PhD, MS, Weill
Cornell Medicine, New York
WASHINGTON
AUDE G. CHAPUIS, MD
“To specify the requirements
of CD8+ and CD4+ T cells for
successful adoptive transfer
in solid tumors” with Philip D.
Greenberg, MD, Fred Hutchinson
Cancer Research Center, Seattle
*Initial Year
MASSACHUSETTS
RYAN B. CORCORAN, MD, PhD
“Defining novel targeted therapy
combination strategies for BRAF
V600 mutant colorectal cancer
with Jeffrey A. Engelman, MD,
PhD, and Keith T. Flaherty, MD,
Massachusetts General Hospital,
Charlestown
ANN MULLALLY, MD*
“Peptide vaccination to
target mutant calreticulin in
myeloproliferative neoplasms”
with Benjamin L. Ebert, MD, and
Jerome Ritz, MD, Brigham and
Women’s Hospital, Boston
NORTH CAROLINA
OREN J. BECHER, MD
“Regional differences in central
nervous system gliomagenesis”
with Darell D. Bigner, MD, PhD,
Katherine E. Warren, MD, and
Michael B. Kastan, MD, Duke
University, Durham
NEW YORK
SARAT CHANDARLAPATY, MD,
PhD
Patterson Trust Clinical
Investigator
“Therapeutic approaches to PI3K-
AKT-mTOR feedback pathways
in breast cancerNeal Rosen, MD,
PhD, and Clifford A. Hudis, MD,
Memorial Sloan Kettering Cancer
Center, New York
TENNESSEE
CHRISTINE M. LOVLY, MD, PhD*
“Developing novel therapeutic
strategies for ALK-fusion positive
lung cancerwith David P.
Carbone, MD, PhD, The Ohio
State University, Columbus, and
Pierre P. Massion, MD, Vanderbilt
University, Nashville
TEXAS
DEEPAK NIJHAWAN, MD, PhD*
“Developing the anti-tumor toxin
CD437 into a new cancer therapy”
with Steve L. McKnight, PhD, and
David Johnson, MD, University
of Texas Southwestern Medical
Center, Dallas
*Initial Year
SARAT CHANDARLAPATY, MD, PhD CHRISTINE M. LOVLY, MD, PhDHEATHER YEO, MD
Select Damon Runyon Clinical Investigators
21
Damon Runyon Fellowship Award Committee
CHAIR
SUSAN L. ACKERMAN, PhD
Howard Hughes Medical Institute
Investigator
Steven W. Kuffler Chair of Biology
Professor Neurobiology Section
and Cell and Molecular
Medicine
University of California San Diego
Medical School
La Jolla, California
VICE CHAIR
PHILIPPE M. SORIANO, PhD
Professor of Developmental and
Regenerative Biology
Professor of Oncological Sciences
Mount Sinai School of Medicine
New York, New York
GREG BARTON, PhD
Professor of Immunology and
Pathogenesis
Class of 1936 Chair, Department
of Molecular and Cell Biology
University of California, Berkeley
Berkeley, California
SHARON Y.R. DENT, PhD
Professor and J. Ralph Meadows
Chair
Department of Molecular
Carcinogenesis
Director, Science Park
Director, Center for Cancer
Epigenetics
The University of Texas
MD Anderson Cancer Center
Smithville, Texas
ADOLFO A. FERRANDO, MD,
PhD
Associate Professor of Pediatrics
and Pathology
Director, WOLF Foundation
Leukemia/Lymphoma Laboratory
Institute for Cancer Genetics
Columbia University Medical
Center
New York, New York
JENNIFER GERTON, PhD
Investigator
Associate Professor, Department
of Biochemistry and
Molecular Biology
The University of Kansas School
of Medicine
Stowers Institute for Medical
Research
Kansas City, Missouri
ANTONIO J. GIRALDEZ, PhD
Investigator
Professor of Genetics
Director of Graduate Studies
Yale University School of
Medicine
New Haven, Connecticut
LUCY A. GODLEY, MD, PhD
Professor, Department of
Medicine
Section of Hematology and
Oncology
Cancer Research Center
The University of Chicago
Medicine
Chicago, Illinois
RACHEL GREEN, PhD
Howard Hughes Medical
Institute Investigator
Professor of Molecular Biology
and Genetics
Johns Hopkins University School
of Medicine
Baltimore, Maryland
RICHARD GREGORY, PhD
Professor, Department of
Biological Chemistry and
Molecular Pharmacology, and
Department of Pediatrics
Harvard Medical School
Harvard Stem Cell Institute
The Stem Cell Program at Boston
Children’s Hospital
Boston, Massachusetts
SUSAN KAECH, PhD
Associate Professor
Department of Immunobiology
Yale University School of
Medicine
New Haven, Connecticut
ALEX L. KOLODKIN, PhD
Howard Hughes Medical Institute
Investigator
Professor
The Solomon H. Snyder
Department of Neuroscience
Johns Hopkins University
School of Medicine
Baltimore, Maryland
CHRISTINA LESLIE, PhD
Associate Member and
Laboratory Head
Computational Biology Program
Memorial Sloan Kettering Cancer
Center
New York, New York
ERIK A. LUNDQUIST, PhD
Professor, Department of
Molecular Biosciences
University of Kansas
Lawrence, Kansas
LYNNE E. MAQUAT, PhD
J. Lowell Orbison Endowed Chair
and Professor
Department of Biochemistry and
Biophysics
School of Medicine and Dentistry
Director, University of Rochester
Center for RNA Biology
Chair, University of Rochester
Graduate Women in Science
University of Rochester
Rochester, New York
TOBIAS MEYER, PhD
Chair, Department of Chemical
and Systems Biology
Mrs. George A. Winzer Professor
in Cell Biology
Stanford University School of
Medicine
Stanford, California
PHILIP A. NEWMARK, PhD
Howard Hughes Medical Institute
Investigator
Professor of Cell and
Developmental Biology
University of Illinois
Urbana, Illinois
ELAINE A. OSTRANDER, PhD *
Chief and NIH Distinguished
Investigator
Cancer Genetics and
Comparative Genomics Branch
Head, Comparative Genetics
Section
National Human Genome
Research Institute
Bethesda, Maryland
*Dr. Ostrander is serving in her personal
capacity.
JOEL ROTHMAN, PhD
Professor and Wilcox Family
Chair in Biotechnology
University of California, Santa
Barbara
Santa Barbara, California
DAVID RUGGERO, PhD
Professor
Helen Diller Family Endowed
Chair in Basic Research
University of California San
Francisco School of Medicine
Member, UCSF Comprehensive
Cancer Center
San Francisco, California
22
Damon Runyon Fellowship Award Committee (Continued)
Damon Runyon Fellowship Awards
CALIFORNIA
Gladstone Institutes
CASEY A. GIFFORD, PhD
HHMI Fellow
“Dissecting the role of pioneer
transcription factors in cancer
progression” with Deepak
Srivastava, MD
Salk Institute
CORINA E. ANTAL, PhD*
“Stromal reprogramming as
a therapeutic approach in
pancreatic cancer” with Ronald
M. Evans, PhD
JEANINE L. VAN NOSTRAND, PhD
“Elucidating the AMPK-
dependent regulation of mTOR
signaling in the metabolic
checkpoint of tumorigenesis”
with Reuben J. Shaw, PhD
Scripps Research Institute
LIRON BAR-PELED, PhD
Lallage Feazel Wall Fellow
“Identification of cysteine
liabilities in NRF2-driven cancers”
with Benjamin F. Cravatt, PhD
EVGENIA N. NIKOLOVA, PhD
Robert Black Fellow
“Recognition of methylated and
specific DNA sequences by
the zinc finger transcriptional
repressor Kaiso and modulation
by other nuclear factors” with
Peter E. Wright, PhD
JOSEPH D. SCHONHOFT, PhD
Merck Fellow
“Probing the relation between
sequence, aggregation and
proteotoxicity in cardiac
amyloidoses caused by free
antibody light chains” with
Jeffery W. Kelly, PhD
Stanford University
CHRISTOPHER J. CAMBIER, PhD*
HHMI Fellow
In vivo characterization of
mycobacterial cording” with
Carolyn R. Bertozzi, PhD
Stanford University School
of Medicine
ANUPAM K. CHAKRAVARTY,
PhD
HHMI Fellow
“Investigating the phenomenon
of epigenetic inheritance
mediated by non-amyloid protein
aggregates” with Daniel F. Jarosz,
PhD
KEREN I. HILGENDORF, PhD
Layton Family Fellow
“Role of ciliary IGF-1/AKT signaling in
ciliogenesis, adipogenesis, and tissue
regeneration” with Peter K. Jackson,
PhD
KATHRIN LEPPEK, PhD
Layton Family Fellow
“Mechanistic characterization
of 5’UTR RNA elements that
confer translational specificity
to shape vertebrate embryonic
development” with Maria Barna,
PhD
YIN LIU, PhD
Layton Family Fellow
“Sensing lung tumors by
pulmonary sensory neurons” with
Mark A. Krasnow, MD, PhD
ANDREW R. NAGER, PhD
Fayez Sarofim Fellow
“Dissecting the mechanism of
selective diffusion into the primary
cilium” with Maxence V. Nachury,
PhD
ROHITH K. SRIVAS, PhD
“Longitudinal profiling of host-
microbiome interactions in obese
patients during drastic weight
loss” with Michael P. Snyder, PhD
ALBERT G. TSAI, MD, PhD*
“Diagnosis of hematologic
malignancies from paucicellular
aspirate material using highly
multiplexed single cell analysis”
with Sean C. Bendall, PhD
University of California,
Berkeley
JUSTIN M. CREST, PhD
“Cells, ECM, and the mechanical
forces that regulate organ shape”
with David Bilder, PhD
FUGUO JIANG, PhD
Merck Fellow
“Molecular mechanisms of guide
RNA: target dsDNA binding and
PAM recognition by CRISPR/
Cas9” with Jennifer A. Doudna, PhD
JULIEN SAGE, PhD
Professor, Department of
Pediatrics (Hematology/
Oncology) and Genetics
Stanford University School of
Medicine
Stanford, California
SOHAIL TAVAZOIE, MD, PhD
Leon Hess Assistant Professor
Head, Elizabeth and Vincent
Meyer Laboratory of Systems
Cancer Biology
The Rockefeller University
New York, New York
MATTHEW G. VANDER HEIDEN,
MD, PhD
Eisen and Chang Career
Development Professor
Associate Professor of Biology
Koch Institute for Integrative
Cancer Research at MIT
Cambridge, Massachusetts
AMY WAGERS, PhD
Professor of Stem Cell and
Regenerative Biology
Harvard University
Cambridge, Massachusetts
HONGTAO YU, PhD
Howard Hughes Medical Institute
Investigator
Professor, Department of
Pharmacology
The University of Texas
Southwestern Medical Center
Dallas, Texas
23
STEVEN LIN, PhD
HHMI Fellow
“Biochemical characterizations
and optimization of CRISPR/
Cas9 for genome engineering”
with Jennifer A. Doudna, PhD
MANDY M. MULLER, PhD
HHMI Fellow
“Widespread RNA destruction
and selective preservation
during viral infection” with Britt
Glaunsinger, PhD
NEEL H. SHAH, PhD
“Interrogating ZAP-70 substrate
recognition using high-
throughput mutant screening”
with John Kuriyan, PhD
NIRANJAN SRINIVAS, PhD*
“Mutual repression, bistability,
and switch-like decisions during
development” with Hernan G.
Garcia, PhD, and Adam P. Arkin,
PhD
DAVID W. TAYLOR, PhD
“Structures of the RNA-targeting
CRISPR-Cas complex Cmrwith
Eva Nogales, PhD
University of California,
Los Angeles
MAGDALENA E. POTOK, PhD
HHMI Fellow
“The relationship between
epigenetic gene silencing, nuclear
architecture, and genome stability”
with Steven E. Jacobsen, PhD
MICHAEL A. CIANFROCCO, PhD
HHMI Fellow
“How does dynein achieve
processivity?” with Andres
Leschziner, PhD, and Samara L.
Reck-Peterson, PhD
ERIC L. VAN NOSTRAND, PhD
Merck Fellow
“Improved RNA binding protein
target identification by eCLIP-
seq and integrative analysis of
RNA regulatory networks across
neuronal differentiation and
medulloblastoma” with Eugene
Yeo, PhD
University of California,
San Francisco
BRITTANY ADAMSON, PhD
HHMI Fellow
“Comprehensive characterization
of the integrated networks that
regulate protein homeostasis
within the mammalian
endoplasmic reticulum” with
Jonathan S. Weissman, PhD
TRACY T. CHOW, PhD
“Investigating and engineering
non-canonical telomere
maintenance mechanisms in
human cells” with Elizabeth H.
Blackburn, PhD
KYLE G. DANIELS, PhD*
“Controlling T cell signaling and
fate choice using synthetic
receptors” with Wendell A. Lim,
PhD
ALBA DIZ MUÑOZ, PhD
“How neutrophils convert changes
in membrane tension to changes
in intracellular signaling during
chemotaxis” with Orion D. Weiner,
PhD, and Daniel A. Fletcher, PhD
MARY W. ELTING, PhD
“Probing how kinetochore-fibers
anchor to spindles to robustly
and accurately segregate
chromosomes” with Sophie
Dumont, PhD
QI HU, PhD
“Design of inhibitors of cancer-
associated mutant GNAS” with
Kevan M. Shokat, PhD
JEFFREY A. HUSSMANN, PhD*
Rebecca Ridley Kry Fellow
“Genome-wide measurement of
ribosome spacing on individual
transcripts” with Carol A. Gross,
PhD
ANKUR JAIN, PhD
“Formation and function of mRNA
processing bodies” with Ronald
D. Vale, PhD
BRIAN J. LAIDLAW*, PhD
“Role of EBI2 in the regulation of
lymphocyte migration during
viral infection and cancer” with
Jason G. Cyster, PhD
JESSICA P. LAO, PhD
“Identifying metabolic targets of
the DNA damage checkpoint”
with David P. Toczyski, PhD
WENYU LUO, PhD
“A Drosophila model to study
resilience to social stress and
depression-like behaviorwith
Yuh-Nung Jan, PhD
GABRIELA C. MONSALVE, PhD
Robert Black Fellow
“Identification and
characterization of plasma
membrane transporters for
glucocorticoids” with Keith R.
Yamamoto, PhD
LYNDSAY M. MURROW, PhD
“Fate specification of mammary
stem cells by cell self-sorting”
with Zev J. Gartner, PhD
DUY P. NGUYEN, PhD
Connie and Bob Lurie Fellow
“Genome editing via an
engineered RNA-guided nuclease
to create cancer genetic models”
with James A. Wells, PhD
THOMAS M. NORMAN, PhD
“Identifying the stochastic
determinants of drug resistance”
with Jonathan S. Weissman, PhD
BEVERLY J. PIGGOTT, PhD
Lefkofsky Family Fellow
“Brain tumor suppression by
mutation(s) of the voltage-gated
sodium channel Para” with Yuh-
Nung Jan, PhD
ALEX POLLEN, PhD
“Regulation of proliferation,
migration and angiogenesis by
genes uniquely expressed in
human neural stem cells” with
Arnold R. Kriegstein, MD, PhD
ERIN F. SIMONDS, PhD
“Single-cell analysis and targeting
of signaling networks in
glioblastoma tumor-initiating
cells” with William A. Weiss, MD,
PhD
JAKOB VON MOLTKE, PhD
HHMI Fellow
“Innate type II cells and wound
healing” with Richard Locksley,
MD
VICTORIA E. WANG, MD PhD
“The role of the c-Met/Hepatocyte
growth factor (HGF) pathway
in drug resistance and tumor
metastasis” with Frank
McCormick, PhD
24
Damon Runyon Fellowship Awards (Continued)
ANDREW L. WOLFE, PhD
“The therapeutic potential and
biological effects of targeting
oncogenic KRAS” with Frank
McCormick, PhD
JIAXI WU, PhD*
“Mechanism of dendritic cell
missing-self recognition and
migration to activate CD4 T cell
responses” with Jason Cyster, PhD
COLORADO
University of Colorado,
Boulder
JENS C. SCHMIDT, PhD
Merck Fellow
“Single-molecule analysis of
telomerase recruitment to
telomeres” with Thomas R. Cech,
PhD
CONNECTICUT
Yale School of Medicine
ZHUOBIN LIANG, PhD*
“Mechanistic dissection of the
Fanconi anemia pathway in
coordinating R-loop processing
and DNA repairwith Patrick Sung,
DPhil, and Gary M. Kupfer, MD
SEYED FAKHREDDIN TORABI,
PhD*
“Evolution of triplex-forming
RNAs from random sequences:
a search for additional MALAT1-
like triplex motifs” with Joan A.
Steitz, PhD
ILLINOIS
The University of Chicago
JOHN D. LEONARD, PhD*
“Self-antigen recognition by
regulatory T cells” with Erin J.
Adams, PhD, and Peter A. Savage,
PhD
SIGRID NACHTERGAELE, PhD
HHMI Fellow
“The dynamic N1-methyladenosine
methylome in eukaryotic mRNA
with Chuan He, PhD
University of Illinois
SARAH Z. TASKER, PhD*
HHMI Fellow
“Synthesis and evaluation of a
collection of complex molecules
biased for penetration of the
blood-brain barrierwith Paul J.
Hergenrother, PhD
MARYLAND
John Hopkins University,
Baltimore
DANIEL H. GOLDMAN, PhD *
Merck Fellow
“Elucidating the role of the exon
junction complex in regulating
translation of spliced mRNA” with
Rachel Green, PhD
CHIH-YUNG LEE, PhD
HHMI Fellow
“Regulation of primordial germ cell
fate in Caenorhabditis elegans
with Geraldine Seydoux, PhD
VU QUANG NGUYEN, PhD
“Role of chromatin organization
in dynamics of transcription
initiation” with Carl Wu, PhD
HANJING PENG, PhD
“Targeting the proteasome using
a hybrid, combinatorial rapafucin
library” with Jun O. Liu, PhD
BORIS ZINSHTEYN, PhD*
HHMI Fellow
“Mechanisms of splicing-
independent nonsense-mediated
mRNA decay” with Rachel Green,
PhD
National Institutes of Health
DANFENG CAI, PhD
“Protein crowding and protein
folding landscapes as predictors
of healthy and diseased cell
states” with Jennifer Lippincott-
Schwartz, PhD
DANIEL E. WEBSTER, PhD
Philip O’B Montgomery, Jr.,
MD, Fellow
“Identification and analysis of
LncRNAs regulating diffuse large
B cell lymphoma” with Louis M.
Staudt, MD, PhD
MASSACHUSETTS
Boston Children’s Hospital
MEGAN L. INSCO, MD, PhD*
“Investigating transcriptional
cyclin dependent kinases as
novel melanoma drug targets”
with Leonard I. Zon, MD
Brigham and Women’s
Hospital
EMMA WATSON, PhD*
Suzanne and Bob Wright Fellow
“Metabolic stress response:
Exploring transcript-level
regulation of metabolic feedback”
with Stephen Elledge, PhD
TIMOTHY D. MARTIN, PhD
Marion Abbe Fellow
“Investigating the role
of aneuploidy and
haploinsufficiency in driving
tumorigenesis” with Stephen J.
Elledge, PhD
Dana-Farber Cancer
Institute
DENNIS L. BUCKLEY, PhD
Merck Fellow
“Development of selective
brodomain inhibitors from dual
brodomain-kinase inhibitors for
the treatment of neuroblastoma”
with James E. Bradner, MD
SERKAN KIR, PhD
Robert Black Fellow
“Identification of factors that
induce brown fat activity in
cancer cachexia” with Bruce M.
Spiegelman, PhD
NEIL T. UMBREIT, PhD
HHMI Fellow
“Elucidating the mechanism of
chromosome bridge resolution”
with David S. Pellman, MD
ERIC S. WANG, PhD*
“Enhancing anti-tumor immunity
via pharmacological inhibition of
kinases” with Nathanael S. Gray,
PhD
25
Harvard T.H. Chan School
of Public Health
CAITLIN A. BRENNAN, PhD
Dennis and Marsha Dammerman
Fellow
“Mechanisms underlying
Fusobacterium nucleatum-driven
colorectal cancer” with Wendy S.
Garrett, MD, PhD
Harvard Medical School
RYAN D. BALDRIDGE, PhD
Fraternal Order of Eagles Fellow
“Investigating the mechanism of
retro-translocation by ERAD” with
Tom A. Rapoport, PhD
JUSTIN A. BOSCH, PhD*
“Elucidating the biological
functions of polypeptide transfer
between animal cells” with
Norbert Perrimon, PhD
IVANA GASIC, DrSc*
Merck Fellow
“Molecular elucidation of the
interphase microtubule integrity
response (MIR)” with Timothy J.
Mitchison, PhD
NATASHA M. O’BROWN, PhD*
“Molecular and cellular
mechanisms of transcytosis
regulation in blood-brain barrier
function” with Chenghua Gu,
PhD
NIKHIL SHARMA, PhD*
“Neural control of breathing” with
Stephen Liberles, PhD
JUSTIN L. SPARKS, PhD
“Replicative helicase bypass
of bulky DNA adducts?” with
Johannes C. Walter, PhD
BENJAMIN M. STINSON, PhD*
“Mechanism of DNA processing
during non-homologous end
joining” with Johannes C. Walter,
PhD, and Joseph L. Loparo, PhD
HUME A. STROUD, PhD
HHMI Fellow
“Understanding the mechanism
and roles of changes in
chromatin composition in the
brain” with Michael E. Greenberg,
PhD
TONY Y. TSAI, MD, PhD
Kenneth G. and Elaine A.
Langone Fellow
“Cell sorting in zebrafish neural
tube development” with Sean G.
Megason, PhD
THOMAS S. VIERBUCHEN, PhD
HHMI Fellow
“Understanding the
developmental programming
and function of the enhancers
that control activity-regulated
transcription in the mammalian
cortex” with Michael E.
Greenberg, PhD
Harvard University
PHILIP B. ABITUA, PhD*
“Functional characterization
of signaling molecules during
zebrafish embryogenesis” with
Alexander F. Schier, PhD
BRIAN J. BELIVEAU, PhD*
HHMI Fellow
"Decoding Polycomb-mediated
gene regulation in single cells
with single-molecule super
resolution imaging and synthetic
biology" with Peng Yin, PhD
AVINASH KHANNA, PhD
Rebecca Ridley Kry Fellow
“Disrupting the protein-protein
interactions of CDK8 to target
cancer” with Matthew D. Shair,
PhD
SUMMER B. THYME, PhD
HHMI Fellow
“Chromatin modifications and
pioneer transcription factors in
development” with Alexander F.
Schier, PhD
ERIC M. WOERLY, PhD
Suzanne and Bob Wright Fellow
Accessing new cancer
therapeutics via an intermolecular
fluorofunctionalization reaction”
with Eric N. Jacobsen, PhD
SUNGWOOK WOO, PhD
HHMI Fellow
“Crystal-free crystallography using
programmable 3D DNA crystal
frameworks” with Peng Yin, PhD
Massachusetts General
Hospital
KAI MAO, PhD
“Mechanisms of xenobiotic
surveillance and regulation” with
Gary Ruvkun, PhD
IVA A. TCHASOVNIKAROVA,
PhD*
“Deciphering the role of chromatin
remodeling in epigenetic
repression by the HUSH complex”
with Robert E. Kingston, PhD
OZLEM YILDIRIM, PhD
HHMI Fellow
“Role of LncRNAs in inheritance
of chromatin states during self-
renewal and differentiation” with
Robert E. Kingston, PhD
Massachusetts Institute
of Technology
ALLISON N. LAU, PhD
Robert Black Fellow
“Understanding metabolic
heterogeneity in pancreatic
cancer” with Matthew G. Vander
Heiden, MD, PhD
JOSE M. ORDOVAS-MONTANES,
PhD*
HHMI Fellow
“Single-cell genomic approaches
for tracing the contribution of
inflammation to human colon
cancer” with Alex K. Shalek, PhD
CHENXI TIAN, PhD
Sherry and Alan Leventhal
Family Fellow
“Understanding the roles
of extracellular matrix
proteins in pancreatic ductal
adenocarcinoma progression”
with Richard O. Hynes, PhD
PETER M. WESTCOTT, PhD*
“Exploiting endogenous
mutational processes in
cancer to enhance response to
immunotherapy” with Tyler Jacks,
PhD
University of Massachusetts
Medical School
GINA V. CALDAS, PhD
Analysis of CSR- function in C.
elegans embryonic cell division”
with Craig C. Mello, PhD
Whitehead Institute for
Biomedical Research
WENWEN FANG, PhD
HHMI Fellow
“Mechanism and regulation of
primary-microRNA processing”
with David P. Bartel, PhD
JUNJIE U. GUO, PhD
Dale F. and Betty Ann Frey Fellow
“Charting the in vivo landscape
of RNA-RNA interactions” with
David P. Bartel, PhD
ALEXANDER M. JAEGER, PhD*
HHMI Fellow
“Surveying the chromatin
architecture shaped by HSF1 in
cancer” with Susan Lindquist, PhD
26
XIAOXIAO S. LIU, PhD
“Examining the biological function
of 5-hmC modification in the
mammalian genome” with Rudolf
Jaenisch, MD
MARIA M. MIHAYLOVA, PhD
Robert Black Fellow
“Examining how nutrient
state dependent metabolic
reprogramming in adult stem
cell niches controls cell renewal,
differentiation and tumorigenesis”
with David M. Sabatini, MD, PhD
MICHIGAN
University of Michigan
SWATHI YADLAPALLI, PhD
HHMI Fellow
“Neural and genetic basis of
metabolic regulation” with Orie T.
Shafer, PhD, and Edgar Meyhofer,
PhD
NEW YORK
Cornell University
SUDEEP BANJADE, PhD*
HHMI Fellow
“Division of labor in ESCRT-
III proteins during polymer
assembly and membrane
remodeling” with Scott D. Emr,
PhD
Cold Spring Harbor
Laboratory
CHRISTINE I. CHIO, PhD
Shirley Stein Fellow
“Regulation of the global redox
landscape: Investigating the
role of Nrf2 in pancreatic cancer
development” with David A.
Tuveson, MD, PhD
Memorial Sloan Kettering
Cancer Center
NICHOLAS ARPAIA, PhD
Robert Black Fellow
“The role of microbiota-derived
metabolic signals in shaping the
intestinal immune landscape”
with Alexander Y. Rudensky, PhD
HARIHAR BASNET, PhD*
“Identifying determinants of
latency in brain metastatic breast
cancer cells” with Joan Massague,
PhD
LYDIA FINLEY, PhD
Jack Sorrell Fellow
“Regulation of cancer cell growth
and survival by the propionate
catabolic pathway” with Craig B.
Thompson, MD
BRYAN C. KING, PhD
Berger Foundation Fellow
AMPK-induced catabolism of
extracellular proteins: a novel
survival mechanism for nutrient-
deprived cancer cells” with Craig
B. Thompson, MD
WILLIAM RAZZELL, PhD
HHMI Fellow
“The role of tension in Hippo
pathway signaling” with Jennifer
A. Zallen, PhD
AARON D. VINY, MD
William Raveis Charitable Fund
Fellow
“Role of the cohesin complex in
oncogenic transformation of
AML” with Ross L. Levine, MD
DMITRIY ZAMARIN, MD, PhD†
Dr. Bart A. Kamen Fellow
“Immunotherapeutic approach
to cancer treatment integrating
oncolytic virotherapy and
immune checkpoint regulation”
with Jedd D. Wolchok, MD, PhD
New York University School
of Medicine
LACY J. BARTON, PhD
“Mechanisms of directed cell
migration in a complex in
vivo environment” with Ruth
Lehmann, PhD
JUNE-YONG LEE, PhD
HHMI Fellow
“Investigation of potential roles of
serum amyloid A in peripheral
Th17 cell pathogenicity” with Dan
R. Littman, MD, PhD
The Rockefeller University
CHAO LU, PhD
Kandarian Family Fellow
“Understanding the mechanism
of histone H3 mutation in cancer
initiation and maintenance” with
C. David Allis, PhD
RAND M. MILLER, PhD
Illini 4000 Fellow
“Chemistry-based dissection of
multidrug resistance efflux pump
mechanisms in living cells” with
Tarun M. Kapoor, PhD
SHRUTI NAIK, PhD
“Immune and epidermal stem cell
cross talk in skin inflammation”
with Elaine V. Fuchs, PhD
ALEXEY A. SOSHNEV, MD, PhD
HHMI Fellow
“The study of linker histone H1 in
transcriptional regulation and
genome organization” with C.
David Allis, PhD
JONATHAN R. WHICHER, PhD
GE Asset Management Fellow
“Structure and mechanism of the
voltage-gated potassium channel
hEag1” with Roderick MacKinnon,
MD
LINGHE XI, PhD*
Dale F. and Betty Ann Frey
Fellow
“WNT signaling and fate
specification of normal versus
tumorigenic stem cells” with
Elaine V. Fuchs, PhD
TEXAS
Baylor College of Medicine
CHRISTINE R. BECK, PhD
HHMI Fellow
“Mechanisms underlying copy
number gain in cancer and
genomic disorder-associated
complex rearrangements” with
James R. Lupski, MD, PhD
University of Texas
Southwestern Medical
Center
LINDSAY B. CASE, PhD*
“Regulation of integrin clustering
on supported lipid bilayers” with
Michael K. Rosen, PhD
ELISE C. JEFFERY, PhD*
“Characterizing a new
hematopoietic stem cell niche
factor” with Sean J. Morrison,
PhD
Damon Runyon Fellowship Awards (Continued)
27
Damon Runyon-Sohn Pediatric Cancer
Fellowship Award Committee
CHAIR
WILLIAM L. CARROLL, MD
Julie and Edward J. Minskoff
Professor of Pediatrics and
Professor of Pathology
Director, Division of Pediatric
Hematology/Oncology
Associate Chair, Clinical and
Translational Research
Stephen D. Hassenfeld Children's
Center for Cancer and Blood
Disorders
New York University Langone
Medical Center
New York, New York
CHAIR ELECT
SCOTT A. ARMSTRONG, MD, PhD
Chair, Department of Pediatric
Oncology
Dana-Farber Cancer Institute
David G. Nathan Professor of
Pediatrics, Harvard Medical
School
Associate Chief of the Division of
Hematology/Oncology at
Boston Children's Hospital
Boston, Massachusetts
PATRICK A. BROWN, MD
Director, Pediatric Leukemia
and Lymphoma Program
Associate Professor, Department
of Oncology
Johns Hopkins University
School of Medicine
Baltimore, Maryland
PETER D. COLE, MD
Associate Professor, Department
of Pediatrics
Albert Einstein College
of Medicine
Montefiore Medical Center
Bronx, New York
LISA R. DILLER, MD
Chief Medical Officer
Dana-Farber Children’s
Hospital Cancer Center
Clinical Director, Pediatric
Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
ADOLFO A. FERRANDO, MD, PhD
Associate Professor of
Pediatrics and Pathology
Director, WOLF Foundation
Leukemia/Lymphoma
Laboratory
Institute for Cancer Genetics
Columbia University
Medical Center
New York, New York
JAMES M. OLSON, MD, PhD
Member
Division of Clinical Research
Fred Hutchinson Cancer
Research Center
Seattle, Washington
MARTINE F. ROUSSEL, PhD
Member and Endowed Chair in
Molecular Oncogenesis
Co-Director, Cancer Center Signal
Transduction Program
Department of Tumor Cell
Biology and Genetics
St. Jude Children’s
Research Hospital
Memphis, Tennessee
(Adjunct Professor,
The University of Tennessee
Health Science Center)
UTAH
University of Utah School
of Medicine
ALESIA N. MCKEOWN, PhD*
HHMI Fellow
“Novel roles for retrogenes in host
immunity” with Nels C. Elde, PhD,
and Cedric Feschotte, PhD
VIRGINIA
Howard Hughes Medical
Institute Janelia Research
Campus
ALBERT TSAI, PhD
“Single-molecule imaging of
transcription factors binding
dynamics in Drosophila embryos”
with Robert H. Singer, PhD
*Initial Year
Physician Scientist
WASHINGTON
Fred Hutchinson Cancer
Research Center
TERA C. LEVIN, PhD
HHMI Fellow
“Master microbial manipulators:
how Wolbachia subvert
Drosophila development” with
Harmit S. Malik, PhD
MATTHEW P. MILLER, PhD
HHMI Fellow
“Regulation of kinetochore
assembly” with Susan Biggins,
PhD
ANTOINE MOLARO, PhD
“Evolutionary and functional
consequences of genetic conflicts
between KRAB-Zinc-Fingers
and endogenous retroviruses in
primate genomes” with Harmit S.
Malik, PhD
ALISTAIR B. RUSSELL, PhD
Merck Fellow
“Impact of heterogeneity on the
cellular recognition of influenza
infection” with Jesse D. Bloom,
PhD
YING QI SHIRLEEN SOH, PhD*
“Mapping paths and mechanisms
of virus-host adaptation” with
Jesse D. Bloom, PhD
University of Washington
RONALD J. HAUSE, PhD
“Function dissection of the
effects of variants of uncertain
significance in TPMT in response
to thiopurine anticancer agents”
with Jay A. Shendure, MD, PhD
YI YIN, PhD*
William Raveis Charitable Fund
Fellow
“Global analysis of DNA break
repair by single-cell sequencing”
with Jay A. Shendure, MD, PhD
28
Damon Runyon-Dale F. Frey Awards
for Breakthrough Scientists
GIRA BHABHA, PhD*
“High-resolution studies of dynein
structure and mechanism” at
New York University Medical
School, New York, New York
ALISTAIR N. BOETTIGER, PhD*
“Using super resolution imaging to
probe molecular mechanisms of
Polycomb silencing” at Stanford
University, Stanford, California
MINGYE FENG, PhD*
“Macrophage-mediated
immunosurveillance in
metastasis” at Stanford
University, Stanford, California
RALPH E. KLEINER, PhD*
“Investigating the importance of
post-translational microtubule
modification using recombinant
acetylated tubulin” at Princeton
University, Princeton, New Jersey
Damon Runyon-Sohn Pediatric Cancer
Fellowship Awards
CALIFORNIA
ÖZLEM AKSOY, PhD
“Understanding the role
of translational control in
humanized mouse models for
medulloblastoma” with Davide
Ruggero, PhD, University of
California, San Francisco
ZHIPENG LU, PhD
Layton Family Fellow of
the Damon Runyon-Sohn
Foundation Pediatric Cancer
Fellowship Award
“Elucidating the role of dynamic
RNA structures in cancer” with
Howard Y. Chang, MD, PhD,
Stanford University School of
Medicine, Stanford
AMIT J. SABNIS, MD†
“Exploiting chaperone
dependence as a novel
therapeutic strategy in alveolar
rhabdomyosarcoma” with Trever
G. Bivona, MD, PhD, University of
California, San Francisco
MARYLAND
STACY L. COOPER, MD†
“The Cebpa +37kb enhancer is a
critical target of transformation
in acute myeloid leukemia” with
Alan D. Friedman, MD, Johns
Hopkins University, Baltimore
MICHAEL A. KOLDOBSKIY, MD,
PhD*
“DNA methylation stochasticity
in pediatric pre-B cell acute
lymphoblastic leukemia” with
Andrew P. Feinberg, MD, Johns
Hopkins University, Baltimore
CARA A. RABIK, MD, PhD*
“Determination of the role of
WT1 in hematopoiesis and
leukemogenesis” with Patrick
A. Brown, MD, Johns Hopkins
University, Baltimore
MASSACHUSETTS
AMANDA L. BALBONI, PhD
“Targeting the EWS-FLI
oncoprotein in Ewing sarcoma
with CDK12/13 inhibitors” with
Kimberly Stegmaier, MD, Dana-
Farber Cancer Institute, Boston
HAIHUA CHU, PhD
“The role of DOT1L in pediatric
leukemias” with Scott A.
Armstrong, MD, PhD, Dana-
Farber Cancer Institute, Boston
SHUIBIN LIN, PhD
“Molecular and cellular
characterization of a novel
LincRNA in neuroblastoma”
with Richard Gregory, PhD,
Boston Children’s Hospital,
Boston
MARK W. ZIMMERMAN, PhD
“Elucidating the mechanism
of CHD5-mediated tumor
suppression in neuroblastoma”
with A. Thomas Look, MD, Dana-
Farber Cancer Institute, Boston
MICHIGAN
CHALLICE L. BONIFANT, MD,
PhD*
“Dual-antigen targeting by ENG-T
cells as improved anti-AML
therapy” with Pavan Reddy, MD,
University of Michigan,
Ann Arbor
NEW YORK
LY P. VU, PhD
“Uncovering the role of RNA-
binding protein Syncrip in acute
myeloid leukemia (AML)” with
Michael G. Kharas, PhD, and Ross
L. Levine, MD, Memorial Sloan
Kettering Cancer Center,
New York
PENNSYLVANIA
TAMARA P. MILLER, MD*
“Improving adverse event
reporting on cooperative
oncology group trials” with
Richard Aplenc, MD, PhD,
Children’s Hospital of
Philadelphia, Philadelphia
TENNESSEE
DAVID W. WOESSNER, PhD
“Discovery of new driver
alterations in childhood ALL
with Charles G. Mullighan, MBBS,
MD, St. Jude Children’s Research
Hospital, Memphis
*Initial Year
Physician Scientist
Damon Runyon-Dale F. Frey Scientist
GIRA BHABHA, PhD
29
CHAIR
WILLIAM G. KAELIN, JR., MD
Howard Hughes Medical
Institute Investigator
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
DAVID P. CARBONE, MD, PhD
Professor, Division of
Medical Oncology
Director, Thoracic
Oncology Center
Comprehensive Cancer Center
The Ohio State University
Columbus, Ohio
PATRICIA A. GANZ, MD
Professor, Schools of Medicine
and Public Health
Director, Division of Cancer
Prevention and Control Research
Jonsson Comprehensive
Cancer Center
University of California, Los Angeles
Los Angeles, California
LUCY A. GODLEY, MD, PhD
Professor
Department of Medicine
Section of Hematology
and Oncology
The University of Chicago
Medicine
Chicago, Illinois
PETER S. NELSON, MD
Member
Program in Prostate
Cancer Research
Division of Human Biology
Fred Hutchison Cancer
Research Center
Professor, Division of
Medical Oncology
Adjunct Professor, Genomic
Sciences and Pathology
University of Washington
School of Medicine
Seattle, Washington
KORNELIA POLYAK, MD, PhD
Professor of Medicine
Department of Medical Oncology
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts
JEREMY N. RICH, MD
Chair, Department Stem Cell
Biology and Regenerative
Medicine
Lerner Research Institute
The Cleveland Clinic Foundation
Cleveland, Ohio
NORMAN E. SHARPLESS, MD
Director, Lineberger
Comprehensive Cancer Center
Wellcome Distinguished
Professor of Cancer Research
Departments of Medicine
and Genetics
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
CASSIAN YEE, MD
Professor, Department of
Melanoma Medical Oncology
Professor, Department of
Immunology
Division of Cancer Medicine
Director, Solid Tumor Cell
Therapy
Center for Cancer Immunology
Research
The University of Texas M.D.
Anderson Cancer Center
Houston, Texas
Damon Runyon Physician-Scientist
Training Award Committee
Damon Runyon Physician-Scientist Training Awards
PAVAN BACHIREDDY, MD
“Coevolution of tumor and T
cell heterogeneity following
immunotherapy” with Catherine
J. Wu, MD, at Dana-Farber Cancer
Institute, Boston, Massachusetts
GIADA BIANCHI, MD*
Damon Runyon-Celgene
Physician-Scientist
“Molecular mechanisms of
ROBO1 in multiple myeloma
pathogenesis” with Kenneth
C. Anderson, MD, Dana-Farber
Cancer Institute, Boston,
Massachusetts
KRISTOPHER R. BOSSE, MD*
“GPC2 as an oncogene and
immunotherapeutic target in
high-risk neuroblastoma” with
John M. Maris, MD, Children’s
Hospital of Philadelphia,
Pennsylvania
JULIA C. CARNEVALE, MD*
“Developing new therapeutic
approaches for pancreatic cancer
with homologous recombination
repair defects” with Alan
Ashworth, PhD, University
of California, San Francisco,
California
MICHAEL W. DRAZER, MD*
“Defining leukomogenic
mechanisms in hereditary
hematologic malignancies” with
Lucy A. Godley, MD, PhD, The
University of Chicago Medicine,
Chicago, Illinois
CAROLYN C. JACKSON, MD,
MPH
“Genetic dissection of pediatric
classic Kaposi sarcoma” with
Jean-Laurent Casanova, MD, PhD,
at Memorial Sloan Kettering
Cancer Center, New York,
New York
DAVID M. KURTZ, MD*
“Response prediction and
personalized therapy from
mathematical modeling of
circulating tumor DNA in non-
Hodgkin lymphoma” with Arash
A. Alizadeh, MD, PhD, Stanford
University School of Medicine,
Stanford, California
LORETTA S. LI, MD
“Mechanisms of disease and
resistance in CRLF2-rearranged
B-cell acute lymphoblastic
leukemia” with David Weinstock,
MD, at Dana-Farber Cancer
Institute, Boston, Massachusetts
*Initial Year
30
Events
DAMON RUNYON BROADWAY TICKETS offers premium seats to all of Broadway’s hits, including
sold-out shows like Hamilton (shown above). We are especially grateful to the Shubert Organization,
Nederlander Productions, Jujamcyn Theaters, and Disney Theatrical Productions for making this
program possible. To purchase tickets and gift certificates, please call (212) 455-0550.
IN NOVEMBER 2015, THE DAMON RUNYON 5K
AT YANKEE STADIUM drew more than 2,700
participants and raised nearly $500,000. The 2015
Runyon 5K was presented by MetLife Foundation,
with additional support from NYSID, Poland Spring,
KRAVE Jerky, Bigelow, Frito Lay, New Era, 24 Hour
Fitness, NBC 4 New York, New York Post, SiriusXM
Satellite Radio and the New York Yankees.
OUR 2016 ANNUAL BREAKFAST RAISED MORE
THAN $1.4 MILLION. Tom Daniel, MD, Chairman,
Celgene Research and Bob Hugin, Executive
Chairman, Celgene Corporation were honored and
introduced by NBC News Special Correspondent
and author Tom Brokaw.
THE WILLIAM RAVEIS CHARITABLE FUND HOSTED TWO RAVEIS RIDE + WALK EVENTS in the
northeast, raising $550,000 for Damon Runyon scientists. Thank you to everyone at William Raveis
for their partnership and support!
31
Your support this year enabled us to fund $17 million of research by the next
generation of leading cancer researchers exploring bold new ideas. Since our founding
in 1946, in partnership with donors across the nation, Damon Runyon has invested
nearly $320 million and funded more than 3,550 young scientists.
Thank You to
Our Donors
Award Sponsors
Accelerating
Cancer Cures
We are grateful to our individual, foundation and corporate sponsors who have
partnered with us to launch new programs or are funding one or more of our
scientists. Donors are able to choose scientists to fund based on location, institution,
research focus or cancer type, and the award can be named in recognition of their
gi. Award sponsors are listed on pages 33-35.
Thank you to Eli Lilly and Company, Celgene, Genentech, Merck, Takeda Pharmaceu-
ticals International, and Pfizer for partnering with us to support the Damon Runyon
Clinical Investigator Award and for helping to foster communication and collaboration
between our scientists and the biopharmaceutical industry.
PETER J. TURNBAUGH, PhD
Laura and Peter Van Camp
have sponsored three Damon
Runyon Innovators through
Nadia's Gift Foundation.
They are pictured here with
Peter J. Turnbaugh, PhD, at
the University of California,
San Francisco, one of their
sponsored scientists.
32
Sponsored Awards
DAMON RUNYON-
RACHLEFF INNOVATION
AWARDS
This award was established
thanks to the vision and
generosity of Debbie and
Andy Rachleff.
EDWARD P. EVANS
FOUNDATION INNOVATOR
Eirini P. Papapetrou, MD, PhD
Icahn School of Medicine
at Mount Sinai
ISLAND OUTREACH
FOUNDATION INNOVATOR
Piero D. Dalerba, MD
Columbia University
NADIA’S GIFT FOUNDATION
INNOVATOR
Peter J. Turnbaugh, PhD
University of California,
San Francisco
CLINICAL
INVESTIGATOR AWARDS
This award was initially
established in partnership
with Eli Lilly and Company. In
addition to the named awards,
it is supported by Accelerating
Cancer Cures, a collaboration
between Damon Runyon and
leading biopharmaceutical
companies.
GORDON FAMILY CLINICAL
INVESTIGATOR
Geoffrey R. Oxnard, MD
Dana-Farber Cancer Institute
JAKE WETCHLER FOUNDATION
FOR INNOVATIVE PEDIATRIC
CANCER RESEARCH CLINICAL
INVESTIGATOR
L. Elizabeth Budde, MD, PhD
City of Hope
METLIFE FOUNDATION
CLINICAL INVESTIGATOR
Christopher E. Barbieri, MD, PhD
Weill Cornell Medicine
RICHARD LUMSDEN
FOUNDATION CLINICAL
INVESTIGATOR
Alex Kentsis, MD, PhD
Memorial Sloan Kettering
Cancer Center
CLINICAL
INVESTIGATOR
CONTINUATION GRANT
Follow-up funding for select
Clinical Investigators has
been provided thanks to the
generosity of the William K.
Bowes, Jr. Foundation.
PATTERSON TRUST CLINICAL
INVESTIGATOR
Sarat Chandarlapaty, MD, PhD
Memorial Sloan Kettering
Cancer Center
FELLOWSHIP AWARDS
The following awards are funded
by donors who have generously
endowed an award in perpetuity
or sponsored an individual Fellow.
DR. BART A. KAMEN FELLOW
Dmitriy Zamarin, MD, PhD
Memorial Sloan Kettering
Cancer Center
BERGER FOUNDATION FELLOW
Bryan C. King, PhD
Memorial Sloan Kettering
Cancer Center
CONNIE AND BOB LURIE
FELLOW*
Duy P. Nguyen, PhD
University of California,
San Francisco
DALE F. AND BETTY ANN
FREY FELLOW*
Linghe Xi, PhD
The Rockefeller University
DENNIS AND MARSHA
DAMMERMAN FELLOW*
Caitlin A. Brennan, PhD
Harvard T.H. Chan School
of Public Health
FAYEZ SAROFIM FELLOW*
Andrew R. Nager, PhD
Stanford University School
of Medicine
FRATERNAL ORDER OF
EAGLES FELLOW
Ryan D. Baldridge, PhD
Harvard Medical School
GE ASSET MANAGEMENT
FELLOW
Jonathan R. Whicher, PhD
The Rockefeller University
HOWARD HUGHES MEDICAL
INSTITUTE (HHMI) FELLOWS
Brittany Adamson, PhD
University of California,
San Francisco
Sudeep Banjade, PhD
Cornell University
Brian J. Beliveau, PhD
Harvard University
Christopher J. Cambier, PhD
Stanford University
Anupam K. Chakravarty, PhD
Stanford University School of
Medicine
Casey A. Gifford, PhD
Gladstone Institutes
Alexander M. Jaeger, PhD
Whitehead Institute for
Biomedical Research
June-Yong Lee, PhD
New York University
School of Medicine
Tera C. Levin, PhD
Fred Hutchinson Cancer
Research Center
We are fortunate to have individual, foundation, and corporate sponsors who
have partnered with us to launch or provide continuing support for specific award
programs. We thank them for their vision.
33
Alesia N. McKeown, PhD
University of Utah School of
Medicine
Matthew P. Miller, PhD
Fred Hutchinson Cancer
Research Center
Mandy M. Muller, PhD
University of California, Berkeley
Sigrid Nachtergaele, PhD
The University of Chicago
Jose M. Ordovas-Montanes, PhD
Massachusetts Institute of
Technology
Magdalena E. Potok, PhD
University of California,
Los Angeles
William Razzell, PhD
Memorial Sloan Kettering
Cancer Center
Alexey A. Soshnev, MD, PhD
The Rockefeller University
Hume A. Stroud, PhD
Harvard Medical School
Sarah Z. Tasker, PhD
University of Illinois
Neil T. Umbreit, PhD
Dana-Farber Cancer Institute
Thomas S. Vierbuchen, PhD
Harvard Medical School
Sungwook Woo, PhD
Harvard University
Swathi Yadlapalli, PhD
University of Michigan
Boris Zinshteyn, PhD
Johns Hopkins University School
of Medicine
ILLINI 4000 FELLOW
Rand M. Miller, PhD
The Rockefeller University
JACK SORRELL FELLOW
Lydia Finley, PhD
Memorial Sloan Kettering
Cancer Center
KANDARIAN FAMILY FELLOW
Chao Lu, PhD
The Rockefeller University
KENNETH G. AND ELAINE A.
LANGONE FELLOW*
Tony Y. Tsai, MD, PhD
Harvard Medical School
LALLAGE FEAZEL WALL
FELLOW*
Liron Bar-Peled, PhD
Scripps Research Institute
LAYTON FAMILY FELLOWS
Keren I. Hilgendorf, PhD
Stanford University School
of Medicine
Kathrin Leppek, PhD
Stanford University School
of Medicine
Yin Liu, PhD
Stanford University School
of Medicine
LEFKOFSKY FAMILY FELLOW
Beverly J. Piggott, PhD
University of California,
San Francisco
MARION ABBE FELLOW*
Timothy D. Martin, PhD
Brigham and Women’s Hospital
MERCK FELLOWS
Dennis L. Buckley, PhD
Dana-Farber Cancer Institute
Ivana Gasic, Dr.Sc.
Harvard Medical School
Daniel H. Goldman, PhD
Johns Hopkins School of
Medicine
Fuguo Jiang, PhD
University of California, Berkeley
Alistair B. Russell, PhD
Fred Hutchinson Cancer
Research Center
Joseph D. Schonhoft, PhD
Scripps Research Institute
PHILIP O’BRYAN
MONTGOMERY, JR., MD,
FELLOW
Daniel E. Webster, PhD
National Institutes of Health
REBECCA RIDLEY KRY
FELLOW*
Jeffrey A. Hussmann, PhD
University of California,
San Francisco
ROBERT BLACK FELLOWS
Nicholas Arpaia, PhD
Memorial Sloan Kettering
Cancer Center
Serkan Kir, PhD
Dana-Farber Cancer Institute
Allison N. Lau, PhD
Massachusetts Institute of
Technology
Maria M. Mihaylova, PhD
Whitehead Institute for
Biomedical Research
Gabriela C. Monsalve, PhD
University of California,
San Francisco
Evgenia N. Nikolova, PhD
Scripps Research Institute
SHERRY AND ALAN
LEVENTHAL FAMILY FELLOW
Chenxi Tian, PhD
Massachusetts Institute
of Technology
SHIRLEY STEIN FELLOW
Christine I. Chio, PhD
Cold Spring Harbor Laboratory
SUZANNE AND BOB WRIGHT
FELLOW*
Emma Watson, PhD
Brigham and Women’s Hospital
WILLIAM RAVEIS CHARITABLE
FUND FELLOWS
Aaron D. Viny, MD
Memorial Sloan Kettering Cancer
Center
Yi Yin, MD
University of Washington
DAMON RUNYON-
SOHN FOUNDATION
PEDIATRIC CANCER
FELLOWSHIP AWARDS
This award program was
launched in partnership with the
generous support of the Sohn
Conference Foundation.
DAMON RUNYON-SOHN
FOUNDATION PEDIATRIC
CANCER FELLOWS
SUPPORTED BY THE SOHN
CONFERENCE FOUNDATION
Özlem Aksoy, PhD
University of California,
San Francisco
Amanda L. Balboni, PhD
Dana-Farber Cancer Institute
Challice L. Bonifant, MD, PhD
University of Michigan
Haihua Chu, PhD
Dana-Farber Cancer Institute
Stacy L. Cooper, MD
Johns Hopkins University
34
$1,000,000 +
**Howard Hughes Medical
Institute
$500,000 TO $999,999
Anonymous
**William K. Bowes, Jr.
Foundation
**Mr. Michael L. Gordon
The Layton Family Fund
**MetLife Foundation
**Sohn Conference Foundation
William Raveis Charitable Fund
$100,000 TO $499,999
Anonymous
**Terry and David Beirne
**Robert Black Charitable
Foundation
Antoinette & Herman
Boehm Foundation
Celgene Corporation
**Estate of Adrienne &
Harry Chamberlain
**Leon & Toby Cooperman
Foundation
Edward P. Evans Foundation
Fidelity Investments Charitable
Gift Fund
**Genentech, Inc.
Estate of Stephanie Goldman
Mr. Robert J. Hugin
**Island Outreach Foundation
**Sherry and Alan Leventhal
Family Foundation
**Lilly Oncology
**Merck & Company, Inc.
**Nadia’s Gift Foundation
Russel H. Norberg Trust
Louis and Rachel Rudin
Foundation, Inc.
Select Equity Group
Silicon Valley Community
Foundation
The Varelas Family Fund
$50,000 TO $99,999
Angelo, Gordon & Co.
Sol and Margaret Berger
Foundation
Estate of Ernest Bittler
Ms. Deborah Coleman and
Mr. Timothy Diggins
Estate of John W.M. Fitton
HHMI Janelia Farm Research
Campus
The Illini 4000 for Cancer
Lefkofsky Family Foundation
MetLife
The Jake Wetchler Foundation
for Innovative Pediatric Cancer
Research
$25,000 TO $49,999
Anonymous
Beacon Capital Partners, LLC
Mr. and Mrs. Lawrence A.
Bossidy
Communities Foundation of
Texas (CFT)
Judy Angelo Cowen Foundation
Estate of Rita Eisenberg
Erlbaum Family Foundation
**Grand Aerie Fraternal Order of
Eagles
Hettinger Foundation
Our Contributors
The Damon Runyon Cancer Research Foundation acknowledges the generosity and
support of the many individual, corporate and foundation donors who supported
our brilliant researchers through gis to the Foundation from July 1, 2015 to
June 30, 2016. Those whose individual lifetime giving is $100,000 or more are in bold,
and those whose lifetime giving exceeds $1 million are noted with two asterisks.**
We are especially grateful to these extraordinarily generous and commied donors.
Michael A. Koldobskiy, MD, PhD
Johns Hopkins University
Cara A. Rabik, MD, PhD
Johns Hopkins University
Amit J. Sabnis, MD
University of California,
San Francisco
Ly P. Vu, PhD
Memorial Sloan Kettering
Cancer Center
David W. Woessner, PhD
St. Jude Children’s Research
Hospital
Mark W. Zimmerman, PhD
Dana-Farber Cancer Institute
LAYTON FAMILY FELLOW OF
THE DAMON RUNYON-SOHN
FOUNDATION PEDIATRIC
CANCER FELLOWSHIP AWARD
Zhipeng Lu, PhD
Stanford University School
of Medicine
DAMON RUNYON
PHYSICIAN-SCIENTIST
TRAINING AWARDS
This award was established
thanks to the generosity of
Damon Runyon Board Members
Leon G. Cooperman and
Michael L. Gordon
DAMON RUNYON-CELGENE
PHYSICIAN-SCIENTIST
Giada Bianchi, MD
Dana-Farber Cancer Institute
*In perpetuity
Sponsored Awards (Continued)
*Our donor lists are checked carefully. However, if you have any corrections or questions, please call 877.722.6237. The full pledge amount is
listed in the year the pledge is made. In subsequent years, actual pledge payments are listed.
35
Mr. Ray Hunt
Independent Charities of
America
Estate of Walter E. Kelley
The Muriel and Norman B.
Leventhal Family Foundation
Mr. and Mrs. David G. Marshall
Gordon H. & Karen M. Millner
Family Foundation
Eugene & Mary Murphy
Charitable Gift Fund
The Pew Charitable Trusts
Mr. Roy Pfautch
The Frances and Abraham
Reichman Charitable Trust
The Bruce Robert Reid Family
Foundation
The San Francisco Foundation
Fred and Donna Seigel
Ms. Karen D. Seitz
The Richard C. and Theresa P.
Smith Memorial Fund
Ms. Cynthia F. Sulzberger and
Mr. Steven B. Green
Tzedakah Foundation
UBS Financial Services, Inc.
$10,000 TO $24,999
Abide Therapeutics
Alexandria Real Estate
Equities, Inc.
Anonymous
Atlantic Health System
Ayco Charitable Foundation
Barthold Family Foundation
Citi
Deutsche Bank Securities Inc.
Mr. and Mrs. Frank Doyle
Echlin Foundation
Lorraine and Bill Egan
Mr. and Mrs. Steven Esrick
The Fine & Greenwald
Foundation, Inc.
GE Asset Management
General Electric Foundation
Goldman, Sachs & Co.
Mr. and Mrs. James Gould
Mr. and Mrs. Scott Greenstein
Mr. Steve Hayden
Estate of Irma T. Hirschl
Ms. Solange and Mr. Michael
Hommel
Ms. Sandra J. Horbach and
Mr. Steven Skoler
Mr. and Mrs. Wayne M. Hummel
Valerie and Jay Ireland
Jewish Communal Fund
Jones Day
J.P. Morgan
Mr. Steven A. Kandarian
**Mr. and Mrs. Kenneth G.
Langone
Charles and Margaret Levin
Family Foundation
Estate of Laurie D. Lima
Mr. and Mrs. Henry Mannix III
Ms. Lynn L. Marks
Joe & Pasena Maroun Family
Foundation
Mr. and Mrs. Gerald M. Marshall
Northern Biologics
Perrigo Company Foundation
Pfizer Inc.
Pharmaceutical Research and
Manufacturers of America
(PhRMA)
Proskauer
Pyramid Hotel Group
Quinn Emanuel Urquhart &
Sullivan, LLP
Mr. and Mrs. Arthur J. Samberg
Schulte Roth & Zabel LLP
Schwab Charitable
Michael V. Seiden, MD, PhD
Henry J. & Kathleen Singer
Family Foundation
Gerri and Andrew Sommers
Family Fund
The Symonds Foundation
Vanguard Charitable Endowment
Program
Mr. and Mrs. John F. Welch, Jr.
Mr. and Mrs. Gary Wolf
Mr. Peter J. Worth, Alliant
Insurance Services
$5,000 TO $9,999
5AM Ventures
Mrs. Carolyn R. Aller
The Allergan Foundation
Anonymous
Barclays
Barnett Family Philanthropic
Fund
Mrs. Barbara Lieb Baumstein
Baupost Group, LLC
The Howard Bayne Fund
Benevity Community Impact
Fund
Mr. and Mrs. Steven H. Berg
Mr. Frank M. Bumstead
Lewis C. Cantley, PhD
Estate of Laurelia M. Clifford
Mr. and Mrs. Martin J. Cohen
Robyn and Tony Coles
Community Health Systems, Inc.
C.R. Bard, Inc.
Ms. Elizabeth B. Dater and
Mr. Mitchell Jennings
Mr. and Mrs. Larry D. Droppa
Mr. and Mrs. Lawrence Foley
Dale & Betty Ann Frey Family
Foundation
Friedman Family Foundation
Ms. Erica Evans-Gioffre and
Mr. Michael Gioffre
Todd R. Golub, MD
Heitman LLC
Mr. and Mrs. Robert M. Hess
Mr. Clair Howey
Interco Charitable Trust
Mr. Scott R. Isdaner
Mrs. Carolyn June Kaplan
Mr. and Mrs. Michael M. Kassen
Mr. Richard A. Konigsberg
Ms. Patty Kosion
Mr. and Mrs. Jeremy R. Kramer
Ms. Ann E. Levine
The Lichtenberger Foundation
Ms. Susan Lipton
Kenneth J. Livak, PhD
Loynd Family Foundation
**Connie and Bob Lurie
Mr. and Mrs. James I. Magid
Ms. Jami W. McKeon
The Leo Model Foundation, Inc.
Alfred L. Morse and Annette S.
Morse Foundation
Mr. and Mrs. Warren K. Myer
Mr. and Mrs. John H. Myers
Nasdaq Inc.
The New York Community Trust
New York State Industries for the
Disabled (NYSID)
Palisade Capital Management
The Penates Foundation
Mr. and Mrs. Rahn Pitzer
Mr. Sheldon Pressler
Mr. and Mrs. Michael Repperger
Rose Family Fund
Mrs. Elizabeth B. Ross
Dr. Lief Sannen and
Mr. Lawrence Wieman
Sanofi Genzyme
Mrs. Mikell M. Smith
Mr. Wayne T. Smith
Mr. Jonathan Sonneborn
Ms. Robie E. Spector
Mr. James D. Staley
Stewart Senter, Inc.
Mrs. Barbara S. Strauss
Mr. and Mrs. John M. Trani
The Turk Family Foundation
Ueberroth Family Foundation
United Way of Metropolitan
Chicago
Mr. and Mrs. E. Scott Urdang
Mr. Jon Vogel
Voya Foundation
Mr. and Mrs. Peter J. Wasserman
Dr. and Mrs. Victor J. Weinstein
Mr. and Mrs. David A. Weiss
$1,000 TO $4,999
Agios
Mr. David Altshuler
Ms. Velma M. Anderson
Anonymous (4)
Mr. and Mrs. Joel Appel
Apple Lane Foundation
Dr. Shelly Artz
Aurora Capital Group
36
Our Contributors (Continued)
Mr. Arthur S. Bahr
Ms. Susannah Bailin
Alan P. Baker, PhD
Ms. Patricia A. Baran
Mr. Richard Barnett
Mr. Tim Barton
Mr. F. Harlan Batrus
Mr. and Mrs. Roger Baumann
BD
Ms. Jill C. Bee
Ms. Robin Bell
Mr. Norman C. Bender
Mr. James Bennett
Ms. Sandye Berger
The Len & Laura Berlik
Foundation, Inc.
Ms. Bonnie Bernard
Mrs. Beth Berns
Donald P. Biek, PhD
Ms. Mindee Blanco
BLL Foundation
Mr. Frederic L. Bloch
Mr. David S. Blue
Mr. William Boeh
Mr. and Mrs. Eugene K. Bolton
Ms. Lisa Boncosky
Mr. Brett Boretti
Mr. and Mrs. Thomas J. Bracken
Mr. John Breslow
Ms. Gloria P. Briggs
Mrs. Samantha Brous
Mr. and Mrs. Richard E. Bruce
Rev. and Mrs. C. Frederick
Buechner
Steven J. Burakoff, MD
Burlingame Foundation
Mr. and Mrs. Arthur B. Calcagnini
Mr. and Mrs. Patrick J. Callan
Mr. Joseph Carrabino, Jr.
CharityBuzz
Ms. Mary F. Cherif
Ms. Sheila A. Chervin
Ms. Elizabeth M. Christiansen
Ms. Deborah Clayman and
Mr. Lawrence Raiman
Mr. Paul Coco
Mr. John T.J. Coe
Mr. and Mrs. Jay L. Cohan
Ms. Irene Cohen
Mr. Samuel T. Cohen
Mr. Frank Conti
Robert N. Cooney, MD and
Ms. Lorrie M. Cooney
Prof. and Mrs. Daniel R.
Cooperman
Mr. Howard J. Cooperman
CORAL Investment Partners
Mr. and Mrs. Michael J. Cosgrove
Mr. and Mrs. Jonathan Crawford
Ms. Maureen Creason
Ms. Dorothy D’Amato
Mr. and Mrs. Pierre J. de Vegh
Mr. Jerome H. Debs II
Mr. and Mrs. Michael
DeDomenico
Ms. Michelle Delong
Ms. Allyson Dematteo
Ms. Lisa Deslauriers
Mr. and Mrs. Philip DeToledo
Mr. Herb Deuschel
Barbara G. Deutsch, MD
Ms. Cynthia W. DeVine
Mr. and Mrs. John Dilley
Ms. Marjorie Doniger
Ronald I. Dozoretz, MD
Mr. Paul Duhaime
Ms. Josephine J. Dumm
Mr. and Mrs. Dexter D. Earle
Mr. and Mrs. Don C. Eddington
Mitzi & Warren Eisenberg Family
Foundation
EOG Resources, Inc.
Ms. Julia Espel
Mr. Robert Ettl
Mr. Robert Evans
Thomas J. Fahey, Jr., MD
Mrs. Roberta Fine
Ms. Leah Finkelstein
FINRA
Robert F. Fisher, PhD
Mr. and Mrs. Mark Fishman
Olivia E. and Adam R. Flatto
Mr. Thomas Florkowski
FORMA Therapeutics
Ms. Linda Frankel
Franklin & Marshall College
Ms. Mary Ann Frenzel
Ms. Effie Fribourg
Mrs. Mary Ann Fribourg
Ms. Terri Friedman
Elaine V. Fuchs, PhD
Gabelli Funds
Mr. Leonard R. Ganz
Mr. and Mrs. Robert W.
Garthwait, Sr.
Richard B. Gaynor, MD
Mr. Ken Globus
Mrs. Isobel Glover
Mr. Steve Goldberg
Ms. Lois Goldring
Mr. Carl Golub
Goulston & Storrs
Grabe Foundation
Ms. Elizabeth A. Gray
Patrick William Gray, PhD
Mrs. Ina Haas and Dr. Jerome
Haas
John W. Hadden II
Mr. and Mrs. Tarek Hallaba
Mr. Ira Hammerman
Mr. Stephen L. Hammerman
Hanover-Horton Schools
Mr. Stephen Hanson
Mr. Ronald F. Hartenbaum
Ms. Elizabeth Hazard
Ms. Alexes Hazen
Healey Family Foundation
Mr. and Mrs. Gary Hellinger
Mr. Richard A. Hoffman and
Ms. Lisa Gross
Mr. and Mrs. Edward E. Hood, Jr.
Mr. and Mrs. Daniel Huber
Ms. Mary I. Hull
Mr. and Mrs. Kevin Hungate
Mr. Andre Hunter
Dr. Phyllis Hyde
Indeed
Mrs. Randi Infusino
J.I. Foundation, Inc.
Jewish Community Federation
Johnson-Miller Foundation
William G. Kaelin, Jr., MD
Mrs. Ellen Schwarzman Katz
Mr. and Mrs. Jordan Katz
Mr. Samuel L. Katz
Mr. and Mrs. James H. Kimenker
Ms. Kathleen King
Ms. Kathryn King
Ms. Sue F. King
Mr. and Mrs. Douglas M. Kinney
Mr. Gerold F.L. Klauer
Klingenstein Fund
Mr. and Mrs. Noah J. Knauf
Mr. John Knopf
Ms. Abby Kohnstamm
Ms. Brenda Korff
Mr. Kyle S. Kozloff
Mr. Lawrence J. Kramer
Ms. Wendy Kreeger
H. Frederick Krimendahl II
Foundation
Estate of Marie Kronman
Mrs. Rebecca R. Kry
Mr. Bryan Labella
Jeremy D. Lack, DPhil
Ms. Janice R. Lane
William D. & E.M. Lane
Foundation
Mr. and Mrs. Mark and Elizabeth
Lazarus
Mr. and Mrs. Steven Lazarus
Levin Capital Strategies, LP
Ms. Ann E. Levine
Mr. Gilbert Levine
Mr. Daniel Levy
Mr. Tom Levy
Mr. and Mrs. William Guy Levy
Levy Family Philanthropic Fund
The Edward F. Limato
Foundation
Mr. Peter P. Lindley
David M. Livingston, MD
Anthony F. LoFrisco, Esq.
Mr. and Mrs. J. Donald
Longenecker
Mr. and Mrs. Curtis Louie
37
Frank E. & Miriam Loveman
Foundation Inc.
Ms. Leslie Lynch
Mr. and Mrs. Timothy Macdonald
Mrs. Barbara Macklowe
Mr. and Mrs. Richard H. Maidman
Mr. and Mrs. James S. Mamary
Ms. Marianne Manzolillo
Mr. David Marcus
Estate of August Mattheyses
Fund
MB Real Estate
Mr. Christopher McGarrigal
Mr. and Mrs. William S. McKiernan
Ms. Christine McManus
Mr. James K. McMorrow
Mr. John McStay
Mr. Gary Meader
Mr. Asheet Mehta
The Messinger Foundation, Inc.
Mr. and Mrs. Fred Middleton
Mr. John Mikhail
Ms. Laura Miller
Mr. and Mrs. Russell C. Minkoff
The Minneapolis Foundation
Sanford W. Morhouse, Esq.
Morphotek
Mr. Bruce Mosler
National Mah Jongg League, Inc.
Dr. Herbert E. Natof
Mr. and Mrs. James L. Neisloss
Network For Good
Mrs. Dorothy Neustadter
New Crossways Foundation
Phillip A. Newmark, PhD
Mr. Timothy O’Connor
Odyssey Reinsurance Company
Mrs. Paula K. Oppenheim
Mr. and Mrs. Peter Busch
Orthwein
Ms. Megan Pace
Mr. and Mrs. Ronald E. Parr
Mr. Stephen Patterson
Ms. Cindy Pearlstein
Ms. Agnes Peelle
Mr. and Mrs. Jack O. Peiffer
Pells Mayton Foundation, Inc.
Mr. and Mrs. Robert M. Pennoyer
Mr. and Mrs. Charles H. Perlman
Perrigo Company
Mr. Fabio D. Petruzziello
Ms. Elizabeth M. Portland and
Mr. Thomas Toce
Dr. and Mrs. Max Proffitt
Ms. Elaine C. Pulk and Mr. James
Wesman
Mr. and Mrs. James M. Pulk
Mr. and Mrs. Robert P. Quinn
Mr. Robert L. Rattet
Ms. Meghan Raveis and Mr. Ryan
Raveis
Mr. Michael Raynes
Dr. Garrett Reisman
Mr. and Mrs. Douglas C. Renfield-
Miller
Mr. Peter E. Ricker
Mr. and Mrs. D. Paul Rittmaster
Mrs. Sheila Robbins
Mr. and Mrs. Gary R. Rockhold
Ms. Elizabeth Roddin
Mr. Steven D. Ross
Mrs. Miriam K. Rothenberg
Mr. Philip R. Rotner
Mr. Joseph D. Roxe
Ms. Julia A. Rubin
Ms. Patricia Ryan
Mr. and Mrs. Donald Sage
Mr. and Mrs. Eric & Corinne
Samson
Mr. and Mrs. Richard L.
Sanderson
Ms. Ilene Sands
Mr. Gary Saretsky
Ms. Linda Saslow
Ms. Alisa Savitz
Mr. and Mrs. Anand R. Savur
Dr. David Schenkein
Mr. Norman R. Schlanger
Ms. Tracy Schmidt
Mr. Paul Schnell
Mendon F. Schutt Family Fund
Mr. Cary M. Schwartz
Mr. and Mrs. David G. Schwartz
Ms. Madeline Schwartz
Mr. Marvin C. Schwartz
Mr. and Mrs. Philip C. Schwartz
Mr. Robert D. Scinto
Ms. Amy Segal
Robert J. Seifer Cancer Research
Foundation
William R. Sellers, MD
Mr. and Mrs. Theodore M. Serure
Ms. Nancy Shapiro
Mr. Steven L. Shapiro
Ms. Victoria Shattner
Mr. Keith S. Sherin
Ms. Lois Sherwin
Mr. Ed Shogan
The Sidewater Family
Foundation, Inc.
Ms. Patricia Silverstein
Samuel C. Silverstein, MD
Nancy Simonian, MD
Ms. Paullina Simons
Mr. Alfred J. Smith
Mr. and Mrs. Jeffrey Q. Smith
Mr. Joseph Smith
Estate of Mildred A. Smith
Ms. Susan L. Solomon
Philippe Soriano, DSc, PhD
Mr. Walter C. Squire
Mr. and Mrs. Kenneth M. Stabler
Mr. Rocco A. Staino
Mr. and Mrs. Alex Stankevich
Mr. Irving Stenn
Mr. Seth F. Stern
Mr. and Mrs. Adam Strum
Mr. Martin J. Sullivan
Mr. Selby Sullivan
Sutro Biopharma
Mr. Steven Taw
Mr. and Mrs. Sanford V. Teplitzky
The David B. Terk Foundation
Mr. J. Ronald Terwilliger
Mr. and Mrs. Ellias
Theodoropoulos
Mr. Joseph M. Thomas
Craig B. Thompson, MD
Mr. John L. Tishman
Mr. and Mrs. Donald W. Torey
Mr. Daniel Tracy
Ms. Dina Treanor and Mr. Jeffrey
Taschler
Mr. Eddie Trump
Mr. Jeffrey Tucker
Daniel P. and Grace I. Tully
Charitable Trust
United Way of Central Maryland
United Way of Martin County
United Way of New York City
Mr. Craig Varrelman
Mr. Sheldon Vidibor
Ms. Kay E. Wagner
Mr. Robert Waldbauer
Ms. Joni L. Walser and Mr.
Andrew B. Church
Mr. and Mrs. Frank J. Walter III
Mr. and Mrs. John T. Walter, Jr.
Warburg Pincus, LLC
Ms. Louise Wasso
Mr. and Mrs. Donald C. Weeden
Ms. Terry Wegner and Mr. Robert
Wegner
Mr. Edwin A. Weiller III
David and Candace Weir
Foundation
James A. Wells, PhD
Ms. Dudley B. White
Dr. Janet M. Widra
Estate of Winifred Wiederkerr
Mr. and Mrs. Frank H. Wildt
Mr. and Mrs. Benjamin J. Winter
Mr. James L. Winter
Mr. Seth Wolchok
Mr. Rod Wood
Woodrow Wilson School
Mrs. Betty G. Young
Mr. Seymour W. Zises
38
Damon Runyon Advisors
The Damon Runyon Advisors act as special advisors to the Foundation in their areas
of expertise and are committed to expanding awareness about our important work to
the next generation of supporters.
JILL E. BARGONETTI, PhD
Professor of Biological Sciences
Hunter College and The
Graduate Center
City University of New York
MS. ERICA EVANS
Managing Director,
Sales Strategy & Institutional
Partnerships
The Hartford Funds
MS. KAREN FANG
Managing Director,
Head of Americas FICC
Sales, Global Banking
and Markets
Bank of America Merrill Lynch
JEREMY D. LACK, DPhil
Partner
Athyrium Capital
MR. GERALD M. MARSHALL
Co-Chairman and CEO
Amerimar Enterprises, Inc.
MS. ANNEMARIE NORRIS
SVP, Group Director,
Behavioral Planning
BBDO
MS. CHRISTINE L. O’DONNELL
Senior Vice President, Market
Philanthropic Director
U.S. Trust, Bank of America
Private Wealth Management
MR. JOHN M. OLIVIERI
Partner
White & Case LLP
MR. JAMES C. RIVIEZZO
Client Director
AIG
MARCEL R. M. VAN DEN BRINK,
MD, PhD
Head, Division of
Hematologic Oncology
Alan Houghton Professor
in Immunology | Member,
Memorial Sloan Kettering
Cancer Center
Professor of Medicine and
Immunology, Weill Cornell
Medicine
MR. GARY I. WOLF
Managing Director
Angelo, Gordon & Co.
Broadway Premier Circle
The Broadway Premier Circle is a group of loyal Damon Runyon Broadway Tickets
customers who have made a special donation in support of cancer research. The Premier
Circle offers members priority access to tickets and other benefits.
Mr. David Altshuler
Mr. and Mrs. Joel Appel
Mrs. Barbara Lieb Baumstein
Ms. Jill C. Bee
Ms. Robin Bell
Mr. Norman C. Bender
Mr. James Bennett
Mr. and Mrs. Robert S. Birch
Ms. Mindee Blanco
Ms. Lisa Boncosky
Mrs. Samantha Brous
Mr. Frank M. Bumstead
Ms. Mary F. Cherif
Ms. Sheila A. Chervin
Mr. Samuel T. Cohen
Robyn and Tony Coles
Ms. Maureen Creason
Mr. Jerome H. Debs II
Ms. Michelle Delong
Ms. Allyson Dematteo
Mr. and Mrs. Philip DeToledo
Mr. Herb Deuschel
Mr. and Mrs. Larry D. Droppa
Mrs. Carol Dubron-Witlin
Mr. Paul Duhaime
Mr. and Mrs. Dexter D. Earle
Mr. and Mrs. Warren Eisenberg
Mr. Robert Ettl
Mr. and Mrs. Mark Fishman
Ms. Linda Frankel
Ms. Mary Ann Frenzel
Ms. Effie Fribourg
Ms. Terri Friedman
Mr. Leonard R. Ganz
Mrs. Isobel Glover
Mr. William Grabe
Mr. Ira Hammerman
Ms. Alexes Hazen
Mr. Andre Hunter
Dr. Phyllis Hyde
Mrs. Randi Infusino
Mr. Scott R. Isdaner
Mrs. Carolyn June Kaplan
Mrs. Ellen Schwarzman Katz
Mr. Samuel L. Katz
Mr. and Mrs. James H. Kimenker
Ms. Kathleen King
Ms. Kathryn King
Ms. Sue F. King
Mr. and Mrs. William B. King
Ms. Abby Kohnstamm
Mr. Richard A. Konigsberg
Mr. Kyle S. Kozloff
Mr. and Mrs. Jeremy R. Kramer
Mr. Lawrence J. Kramer
Ms. Wendy Kreeger
Ms. Ellen S. Lane
Mr. and Mrs. Mark and
Elizabeth Lazarus
Ms. Ann E. Levine
Mr. Doug Levine
Mr. and Mrs. William Guy Levy
Mr. Daniel Levy
Ms. Susan Lipton
Kenneth J. Livak, PhD
Mr. and Mrs. James I. Magid
Mr. and Mrs. Henry Mannix III
Mr. David Marcus
Ms. Jami W. McKeon
Mr. John Mikhail
Ms. Kimberly Terk Murphy
Mr. and Mrs. James L. Neisloss
Mr. and Mrs. Peter Busch
Orthwein
Ms. Megan Pace
Ms. Cindy Pearlstein
Ms. Agnes Peelle
Mr. Sheldon Pressler
Ms. Elaine C. Pulk and
Mr. James Wesman
Mrs. Sheila Robbins
39
Discovery Society
Discovery Society members are valued supporters who have provided for the Damon
Runyon Cancer Research Foundation through planned gifts. These donations provide a
vital source of support and fuel future breakthroughs against cancer.
Mr. Philip R. Rotner
Mr. Joseph D. Roxe
Ms. Julia A. Rubin
Ms. Ilene Sands
Mrs. Jane Santinelli
Mr. Gary Saretsky
Ms. Linda Saslow
Ms. Tracy Schmidt
Mr. and Mrs. Philip C. Schwartz
Mrs. Cipora Schwartz
Ms. Madeline Schwartz
Ms. Nancy Shapiro
Mr. Steven L. Shapiro
Ms. Elaine M. Addis
Anne C. Burkholder, PhD, and
Stephen P. Eisenberg, PhD
Mr. and Mrs. Martin J. Cohen
Ms. Ann K. Cote
Mrs. Phyllis Farleigh
Robert F. Fisher, PhD
Ms. Mary Ann Frenzel
Richard B. Gaynor, MD
Mr. Rick J. Govern
Mr. and Mrs. William C. Hines
Mrs. Rebecca R. Kry
Broadway Premier Circle (Continued)
Ms. Victoria Shattner
Ms. Barbara Sherman
Ms. Lois Sherwin
The Sidewater Family
Foundation, Inc.
Mr. Alfred J. Smith
Dr. David Hamilton Smith
Ms. Susan L. Solomon
Mr. Jonathan Sonneborn
Mr. Walter C. Squire
Mr. Selby Sullivan
Mr. Steven Taw
Mr. J. Ronald Terwilliger
Mr. Joseph M. Thomas
Mr. Jeffrey Tucker
Mr. and Mrs. E. Scott Urdang
Ms. Kay E. Wagner
Mr. and Mrs. Peter J. Wasserman
Mr. Edwin A. Weiller III
Mr. and Mrs. David Weiner
Dr. and Mrs. Victor J. Weinstein
Dr. Janet M. Widra
Owen N. Witte, MD
Mr. and Mrs. Gary Wolf
Lewis L. Lanier, PhD
Mr. and Mrs. Leo LoFrisco
Mr. D.G. Mitchell
Mr. and Mrs. Ronald E. Parr
Mr. and Mrs. Rick Robinson
Mr. Seymour Rosenheck
Mrs. Esther E. Schwartz
Ms. Phoebe H. Showers
Mrs. Carol H. Stix
Ms. Rose Vaccariello
Mr. and Mrs. Arthur Walker
Aladdin
Beautiful-The Carole King Musical
The Book of Mormon
A Bronx Tale
Chicago
The Color Purple
Dear Evan Hansen
The Encounter
Falsettos
Fiddler on the Roof
TICKETS AVAILABLE FOR
The Front Page
Hamilton
The Humans
In Transit
Jersey Boys
Kinky Boots
Les Liaisons Dangereuses
The Lion King
Matilda
Natasha, Pierre & The
Great Comet of 1812
Oh, Hello on Broadway
On Your Feet
Phantom of the Opera
School of Rock
Something Rotten!
Waitress
Wicked
Damon Runyon Broadway Tickets
Support cancer research from the best seats in the theater. Your purchase
includes a voluntary tax-deductible donation.
Our gift certificates are perfect for friends and loved ones this holiday season. We'll send a card
on your behalf—they can choose the show and date at their convenience, even Hamilton!
To find out more, call 212.455.0550 or visit damonrunyon.org/broadway
40
DAMON RUNYON CANCER RESEARCH FOUNDATION
ANNUAL REPORT 2016
Ways to Give
DONATE ONLINE BY VISITING US
AT DAMONRUNYON.ORG/DONATE.
CALL US AT 1.877.7CANCER OR 1.877.722.6237,
9AM 5PM ET, MONDAY TO FRIDAY
DAMON RUNYON CANCER
RESEARCH FOUNDATION
55 BROADWAY, SUITE 302
NEW YORK, NY 10006
Please remember us in your will or trusts. Visit
WWW.DAMONRUNYON.ORG/GET-INVOLVED
for more information about planned giving.
ONE HUNDRED PERCENT
of your donation is tax-deductible.
Many companies match the gifts of
employees, spouses and retirees.
41
OUR OVERHEAD IS PAID FROM OUR ENDOWMENT AND
DAMON RUNYON BROADWAY TICKETS, ALLOWING
100%
of your donation to support cancer research.
Financial Summary
Fiscal Year 2016
REVENUE AND
APPROPRIATION FROM
ENDOWMENT
EXPENSES
Award Programs 87.1%
Fundraising 10.4%
General Administration 2.5%
$22.1
MILLION
$22.1
MILLION
Contributions 45%
Appropriation from
Endowment 45.9%
Bequests & Trusts 3.4%
Misc. Income 3.6%
Damon Runyon
Broadway Tickets 2.1%
In Fiscal Year 2016, based on a comprehensive review of our award programs by the Scientific
Committee of our Board of Directors, we continued the implementation of several changes
to our programs, substantially increasing the duration, dollar amount, and number of awards.
These changes were a result of a strategic decision to utilize our endowment, as well as
increase donations, to fund new opportunities in cancer research and accelerate progress. In
FY2016, we used $10 million from our endowment to support our work.
As in previous years, the financial activities of the Damon Runyon Cancer Research Foundation
were audited by RMS US LLP. Below is a snapshot of FY2016. For our complete audited
financial statements, please visit our website at www.damonrunyon.org.
SUMMARY OF BALANCE SHEETS
42
$145,440,975 $135,646,786
$25,930,143
$29,816,543
$119,510,832 $105,830,243
Total Assets
Total Liabilities
Total Net Assets
2015 2016
ONE EXCHANGE PLAZA
55 Broadway, Suite 302
New York, New York 10006
1.877.7CANCER
T 212.455.0500 F 212.455.0509
www.damonrunyon.org
To accelerate breakthroughs, the
Damon Runyon Cancer Research
Foundation provides today’s best
young scientists with funding to
pursue innovative cancer research.
Our goal is to foster the talent
capable of revolutionizing the
prevention, detection, and treatment
of all forms of cancer.